<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-10T16:44:39+00:00">
  <iati-activity last-updated-datetime="2026-11-10T13:42:47+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-ZAF-C-NDOH-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Investing for Impact against Tuberculosis and HIV - South Africa (01-Apr-2016-31-Mar-2019)</narrative>
    </title>
    <description type="1">
      <narrative>South Africa, TB/HIV, National Department of Health of the Republic of South Africa</narrative>
    </description>
    <description type="2">
      <narrative>Goals: Ensuring an enabling and accessible legal framework that protects and promotes human rights in order to support implementation of the NSP; Initiating at least 80% of eligible patients on antiretroviral treatment, with 70% alive and on treatment five years after initiation; Reducing new HIV infections by at least 50%, using combination prevention approaches; Reducing self-reported stigma related to HIV and TB by at least 50%; Reducing the number of new TB infections and deaths from TB by 50%. Objectives: Addressing Social and Structural Drivers of HIV and TB Prevention, Care and Impact; Ensuring protection of human rights and improving access to justice; Preventing New HIV, STI and TB Infections; Sustaining Health and Wellness.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="10" role="2" crs-channel-code="12001">
      <narrative>National Department of Health of the Republic of South Africa</narrative>
    </participating-org>
    <participating-org type="10" role="4" crs-channel-code="12001">
      <narrative>National Department of Health of the Republic of South Africa</narrative>
    </participating-org>
    <other-identifier ref="ZAF-C-NDOHP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2016-04-01" />
    <activity-date type="2" iso-date="2016-04-01" />
    <activity-date type="3" iso-date="2019-03-31" />
    <activity-date type="4" iso-date="2019-03-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>John Ochero</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>john.ochero@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="ZA" percentage="100">
      <narrative>South Africa</narrative>
    </recipient-country>
    <sector vocabulary="1" code="13040" percentage="50">
      <narrative>TB/HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="50">
      <narrative>TB/HIV</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <transaction ref="8a1c598e-0495-4525-9050-0e7d172ce181">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-07-25" />
      <value currency="USD" value-date="2016-07-25">58900330.00</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="13e9d9dc-47bf-4f39-aecc-5ce4e29e1826">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-07-26" />
      <value currency="USD" value-date="2016-07-26">12669796.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="506772cc-a7f1-4ba0-bade-2e44d719b324">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-09-06" />
      <value currency="USD" value-date="2016-09-06">8050971.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b445338e-2bec-4602-8b09-313065434e70">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-12-13" />
      <value currency="USD" value-date="2016-12-13">9627301.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c9f91d98-ff6b-4102-baa8-a7da30bd7fd3">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-05-09" />
      <value currency="USD" value-date="2017-05-09">12584310.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b68d5f35-47b0-4cb6-8196-24cd3f94195c">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-07-27" />
      <value currency="USD" value-date="2017-07-27">8350299.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3c25738a-2383-4b4f-a9fa-52d00c7e244d">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-10-05" />
      <value currency="USD" value-date="2017-10-05">75659.44</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6ab6ac32-254d-4f8f-bf3e-1e4d69c970e0">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-11-07" />
      <value currency="USD" value-date="2017-11-07">7541993.56</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9d24bc87-c608-4814-b1d3-3fe826620b6b">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-12-15" />
      <value currency="USD" value-date="2017-12-15">50000.00</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="872b0097-3756-4603-8f7b-aebe18331558">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-12-18" />
      <value currency="USD" value-date="2017-12-18">18319748.13</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f89ec1a6-bc09-409e-89f1-ca5a9d6497a2">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-01-16" />
      <value currency="USD" value-date="2018-01-16">7527394.13</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="373f371e-0f96-4153-bcb3-be4b4c934521">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-04-20" />
      <value currency="USD" value-date="2018-04-20">-50000.00</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a024bdbe-6c75-4f63-aa2a-6a2735a39dde">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-04-20" />
      <value currency="USD" value-date="2018-04-20">100000.00</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7727f43c-9239-4c2f-aa9e-b855a9cb4629">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-05-08" />
      <value currency="USD" value-date="2018-05-08">10792354.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="45873439-7325-4b47-8747-4964a086bc05">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-08-17" />
      <value currency="USD" value-date="2018-08-17">13890744.00</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="541615d0-d9d9-4219-9fe0-e99f5b2da2dc">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-08-21" />
      <value currency="USD" value-date="2018-08-21">13890744.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="353f03b8-dc8b-46ae-9dfe-b25a1e34c830">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-12-17" />
      <value currency="USD" value-date="2018-12-17">35343914.40</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3dc4040b-96bd-4fef-9bee-371a561c3f32">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-12-18" />
      <value currency="USD" value-date="2018-12-18">17193281.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9d6587a9-1604-4d4c-b666-d34e9b45ef27">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-12-31" />
      <value currency="USD" value-date="2018-12-31">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ecbb812d-185f-4f74-8a35-3ec161594428">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-03-21" />
      <value currency="USD" value-date="2019-03-21">10117626.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="52130a0d-655c-49b7-a068-49f916d082e4">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-05-04" />
      <value currency="USD" value-date="2020-05-04">-8033007.40</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="56f014e0-e9bf-4e8e-95f9-7b16a7e2714f">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-05-04" />
      <value currency="USD" value-date="2020-05-04">-50000.00</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a9bf0dbe-3f48-41dd-906a-d6e5dd753d7d">
      <transaction-type code="7" />
      <transaction-date iso-date="2020-07-10" />
      <value currency="USD" value-date="2020-07-10">92939.90</value>
      <description>
        <narrative>Funds returned to the Global Fund from ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a5c25511-855c-468f-beca-442931834ff4">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-07-17" />
      <value currency="USD" value-date="2020-07-17">-92939.90</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/ZAF-C-NDOH" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-10" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2015" iso-date="2015-12-31">
          <comment>
            <narrative>Numerator: 11538; Denominator: 18734; Percentage: 61.6%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-04-01" />
          <period-end iso-date="2016-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 5218; Denominator: 7089; Percentage: 73.6%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5779; Denominator: 5644; Percentage: 102.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-10-01" />
          <period-end iso-date="2017-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 10436; Denominator: 14177; Percentage: 73.6%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 11617; Denominator: 14177; Percentage: 81.9%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-04-01" />
          <period-end iso-date="2017-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 6675.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4833.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-10-01" />
          <period-end iso-date="2018-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 13350.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 10208.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-04-01" />
          <period-end iso-date="2018-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 8544.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4709.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-10-01" />
          <period-end iso-date="2019-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 17087.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 9476.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive registered TB patients given anti-retroviral therapy during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive registered TB patients given anti-retroviral therapy during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31" value="78.9" />
        <period>
          <period-start iso-date="2016-04-01" />
          <period-end iso-date="2016-09-30" />
          <target value="80">
            <comment>
              <narrative>Numerator: 71903; Denominator: 89878.</narrative>
            </comment>
          </target>
          <actual value="79.7">
            <comment>
              <narrative>Numerator: 51760; Denominator: 64904.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-10-01" />
          <period-end iso-date="2017-03-31" />
          <target value="80">
            <comment>
              <narrative>Numerator: 143805; Denominator: 179756.</narrative>
            </comment>
          </target>
          <actual value="88.2">
            <comment>
              <narrative>Numerator: 128631; Denominator: 145755.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-04-01" />
          <period-end iso-date="2017-09-30" />
          <target value="85">
            <comment>
              <narrative>Numerator: 76397; Denominator: 89878.</narrative>
            </comment>
          </target>
          <actual value="82.4">
            <comment>
              <narrative>Numerator: 24272; Denominator: 29456.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-10-01" />
          <period-end iso-date="2018-03-31" />
          <target value="85">
            <comment>
              <narrative>Numerator: 152793; Denominator: 179756.</narrative>
            </comment>
          </target>
          <actual value="83.9">
            <comment>
              <narrative>Numerator: 98818; Denominator: 117724.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-04-01" />
          <period-end iso-date="2018-09-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 80890; Denominator: 89878.</narrative>
            </comment>
          </target>
          <actual value="86.9">
            <comment>
              <narrative>Numerator: 26020; Denominator: 29932.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-10-01" />
          <period-end iso-date="2019-03-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 161780; Denominator: 179758.</narrative>
            </comment>
          </target>
          <actual value="85.2">
            <comment>
              <narrative>Numerator: 73279; Denominator: 86038.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV currently receiving antiretroviral therapy</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV currently receiving antiretroviral therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2015" iso-date="2015-12-31" value="76">
          <comment>
            <narrative>Numerator: 3125977; Denominator: 4113977.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-04-01" />
          <period-end iso-date="2016-09-30" />
          <target value="56.6">
            <comment>
              <narrative>Numerator: 3603902; Denominator: 6363000.</narrative>
            </comment>
          </target>
          <actual value="54.9">
            <comment>
              <narrative>Numerator: 3494260; Denominator: 6363000.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-10-01" />
          <period-end iso-date="2017-03-31" />
          <target value="75.4">
            <comment>
              <narrative>Numerator: 4800000; Denominator: 6363000.</narrative>
            </comment>
          </target>
          <actual value="60.1">
            <comment>
              <narrative>Numerator: 3826622; Denominator: 6363000.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-04-01" />
          <period-end iso-date="2017-09-30" />
          <target value="86.6">
            <comment>
              <narrative>Numerator: 5500000; Denominator: 6350000.</narrative>
            </comment>
          </target>
          <actual value="62.3">
            <comment>
              <narrative>Numerator: 3955185; Denominator: 6350000.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-10-01" />
          <period-end iso-date="2018-03-31" />
          <target value="59.6">
            <comment>
              <narrative>Numerator: 4200000; Denominator: 7046301.</narrative>
            </comment>
          </target>
          <actual value="59.5">
            <comment>
              <narrative>Numerator: 4189070; Denominator: 7046301.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-04-01" />
          <period-end iso-date="2018-09-30" />
          <target value="64.6">
            <comment>
              <narrative>Numerator: 4600000; Denominator: 7121759.</narrative>
            </comment>
          </target>
          <actual value="61.1">
            <comment>
              <narrative>Numerator: 4354123; Denominator: 7121759.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-10-01" />
          <period-end iso-date="2019-03-31" />
          <target value="70.2">
            <comment>
              <narrative>Numerator: 5000000; Denominator: 7121759.</narrative>
            </comment>
          </target>
          <actual value="65">
            <comment>
              <narrative>Numerator: 4629831; Denominator: 7121759.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-10T13:42:47+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-ZAF-C-NDOH-2</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Investing for impact against Tuberculosis and HIV - South Africa (01-Apr-2019-31-Mar-2022)</narrative>
    </title>
    <description type="1">
      <narrative>South Africa, TB/HIV, National Department of Health of the Republic of South Africa</narrative>
    </description>
    <description type="2">
      <narrative>Goals: Accelerate prevention to reduce new HIV and TB infections and STIs; Reduce morbidity and mortality by providing treatment, care and adherence support for all; Reach all key and vulnerable populations with customised and targeted interventions; Address the social and structural drivers of HIV, TB and STIs, and lin these effort to the National Development Plan; Ground the response to HIV, TB and STIs in human rights principles and approaches; Promote leadership and shared accountability for sustainable response to HIV, TB and STIs; Mobilise resources and maximise efficiencies to support the achievment of NSP goals and ensure a sustainable approach; Strengthen strategic information to drive progress towards achievement of NSP goals. Objectives: 1.1 Reduce new HIV infections to less than 100,000 by 2022 through combination prevention interventions; 2.1 Implement the 90-90-90 strategy for HIV; 2.2 Implement the 90-90-90 Strategy for TB; 3.1 Increase engagment, collaboration and advocacy of key and vulnerable populations in the development and implementation of social and health support activities; 3.2 To provide an enabling environment to increase access to health services by key and vulnerable populations; 4.1 Implement social and behaviour change programmes to address key drivers of the epidemic and build social cohesion; 4.4 Implement and scale up a package of harm reduction interventions for harmful use of alcohol and drugs in all districts; 4.5 Implement economic strengthening programmes with a focus on youth in priority focus districts; 5.3 Promote an environment that enables and protects human and legal rights and prevents stigma and discrimination; 6.1 Strengthen AIDS Councils to provide effective co-ordination and leadership of all stakeholders for shared accountability in the implementation of the NSP; 7.1 Improve efficiency and mobilise sufficient resources to achieve the goals, objective and targets of the NSP; 8.1 Optimise routinely collected strategic health information for data utilisation in decision making.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="10" role="2" crs-channel-code="12001">
      <narrative>National Department of Health of the Republic of South Africa</narrative>
    </participating-org>
    <participating-org type="10" role="4" crs-channel-code="12001">
      <narrative>National Department of Health of the Republic of South Africa</narrative>
    </participating-org>
    <other-identifier ref="ZAF-C-NDOHP02" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2019-04-01" />
    <activity-date type="2" iso-date="2019-04-01" />
    <activity-date type="3" iso-date="2022-03-31" />
    <activity-date type="4" iso-date="2022-03-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>John Ochero</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>john.ochero@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="ZA" percentage="100">
      <narrative>South Africa</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="47.52">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="13040" percentage="29.01">
      <narrative>HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="23.47">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="01b3eb9e-75bd-47fc-833d-1b5266368425" percentage="1.64">
        <description>
          <narrative>HIV -&gt; Prevention programs for adolescents and youth, in and out of school -&gt; HIV testing services for adolescents and youth, in and out of school</narrative>
        </description>
      </budget-item>
      <budget-item code="557c641d-d721-482b-a47f-096caa882957" percentage="0.1">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Human rights and medical ethics related to HIV and HIV/TB for health care providers</narrative>
        </description>
      </budget-item>
      <budget-item code="d3f0ee90-71c1-4dad-ad46-19e91d25c002" percentage="27.26">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; HIV care</narrative>
        </description>
      </budget-item>
      <budget-item code="955f4722-71fb-4b46-8bd2-2d741fdad76b" percentage="0.09">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="e07bbbe4-54fa-4084-a6fe-7f1c9c3b77b6" percentage="5.99">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="3e9642ae-693f-47d9-95b3-3cf2c3e2e170" percentage="1.21">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Other community responses and systems intervention(s)</narrative>
        </description>
      </budget-item>
      <budget-item code="a5a90010-4e5c-42a4-a6f3-569620e48a90" percentage="0.04">
        <description>
          <narrative>RSSH -&gt; RSSH: Financial management systems -&gt; Other financial management intervention(s)</narrative>
        </description>
      </budget-item>
      <budget-item code="b0b850b8-142b-4100-bd18-2da244fde07f" percentage="0.16">
        <description>
          <narrative>RSSH -&gt; RSSH: Financial management systems -&gt; Public financial management (country or donor harmonized) systems</narrative>
        </description>
      </budget-item>
      <budget-item code="79f56a06-e483-471f-ad35-812bf3014339" percentage="0.07">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Administrative and finance data sources</narrative>
        </description>
      </budget-item>
      <budget-item code="004842a6-d6eb-49a2-a763-882fd356689a" percentage="0.55">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="5221e091-6641-4eee-b68d-9b5879a96a78" percentage="3.97">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="ad843466-bf87-44ef-9b83-217a8cfb22d0" percentage="8.89">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; National costed supply chain master plan, and implementation</narrative>
        </description>
      </budget-item>
      <budget-item code="a1d59f86-a576-4ed5-bc14-b2d9fc2c3967" percentage="1.78">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; National product selection, registration and quality monitoring</narrative>
        </description>
      </budget-item>
      <budget-item code="7319638f-aa8e-41bc-b90c-e0eb35b6797c" percentage="0.73">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Other procurement supply chain management intervention(s)</narrative>
        </description>
      </budget-item>
      <budget-item code="5e616c4b-3854-4008-8caa-4cb786ae6fe1" percentage="0.39">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Engaging all care providers (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="3637a37c-6acc-4a5b-b7e4-00640fd7e2ec" percentage="5.28">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="f7014493-22e9-4c03-96d0-144fbb3a254f" percentage="30.01">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="e6d6284e-9e23-498f-91ee-4393f4aa49a1" percentage="0.02">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Collaborative activities with other programs and sectors (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="a0ec8795-341f-4d7b-9bdd-618cfc782127" percentage="1.06">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Community TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="accfbf9b-023f-4bd8-b952-bf1cb13e8e9b" percentage="0.15">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Prevention (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="edbef7da-ca99-4741-8ce0-ea3ba6cd3d3b" percentage="0.07">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="03642497-8d31-43e6-9dc7-a1d83d6bad5e" percentage="0.27">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; Engaging all care providers (TB/HIV)</narrative>
        </description>
      </budget-item>
      <budget-item code="92e11022-488c-4948-abb3-b61f3d9ca4f6" percentage="10.27">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2019-01-01" />
      <period-end iso-date="2019-12-31" />
      <value currency="USD" value-date="2019-01-01">6986681.23</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2020-01-01" />
      <period-end iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-01-01">36444654.67</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2021-01-01" />
      <period-end iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-01-01">142491245.89</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2022-01-01" />
      <period-end iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-01-01">78676982.71</value>
    </budget>
    <capital-spend percentage="3.65" />
    <transaction ref="206b4022-b578-4e79-b710-9f81657bace3">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-06-26" />
      <value currency="USD" value-date="2019-06-26">91747794.95</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fcce04da-f6c8-4a2d-91b3-e8098bbcbef4">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-06-27" />
      <value currency="USD" value-date="2019-06-27">10013833.35</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="29467c51-1a06-40db-9e06-3f3cb748cd3a">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-08-07" />
      <value currency="USD" value-date="2019-08-07">50000.00</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c3c64e32-60b9-47ef-9628-01e41480d0e5">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-11-12" />
      <value currency="USD" value-date="2019-11-12">9110243.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c163ec85-9525-44df-9ca6-23af0b6f2e7b">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-02-11" />
      <value currency="USD" value-date="2020-02-11">13703383.88</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="099b5b39-0c27-4c91-a750-2fde17a458dd">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-02-18" />
      <value currency="USD" value-date="2020-02-18">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6eab3f81-a0c6-419a-95f9-f5d1140b8a73">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-05-13" />
      <value currency="USD" value-date="2020-05-13">12191426.36</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c2bcc355-de2c-4de0-8803-939e3f64acc8">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-06-26" />
      <value currency="USD" value-date="2020-06-26">50000.00</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="365cfe4f-d636-4454-992e-7c8f3dd4ae92">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-07-29" />
      <value currency="USD" value-date="2020-07-29">11208339.36</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2db3b620-8a98-4bbe-821a-bc1fade070a1">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-11-05" />
      <value currency="USD" value-date="2020-11-05">2671829.55</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="bf01703c-70cd-4e1b-a008-5bae9d4cba4e">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-12-09" />
      <value currency="USD" value-date="2020-12-09">2559146.84</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c3403d4e-3073-4f96-9067-f2f00cb2a300">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-12-09" />
      <value currency="USD" value-date="2020-12-09">6997749.39</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a0f2a5c5-4514-496d-a6be-51417e07199c">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-12-09" />
      <value currency="USD" value-date="2020-12-09">6735572.83</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a3265067-2f7d-484d-9670-68bb826b6e8a">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-12-09" />
      <value currency="USD" value-date="2020-12-09">10688462.81</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d7fa54a5-654b-458d-872d-df8da6d473ff">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-02-03" />
      <value currency="USD" value-date="2021-02-03">51701657.34</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2199b437-b375-4ad5-9522-650b2b02e7a0">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-02-03" />
      <value currency="USD" value-date="2021-02-03">-8539637.13</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8ece9ab7-d96f-4ffd-98b8-6a0563a93518">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-02-05" />
      <value currency="USD" value-date="2021-02-05">5711761.29</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7d7bcdd6-092b-46ff-93b8-25b16b1e7752">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-02-05" />
      <value currency="USD" value-date="2021-02-05">6542951.88</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="25968f3e-a5f2-44ac-8148-6d217509b0cd">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-02-05" />
      <value currency="USD" value-date="2021-02-05">4126697.12</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f2abf78f-054b-484d-8795-eb9dae62ee68">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-03-12" />
      <value currency="USD" value-date="2021-03-12">-2671829.55</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="49b9e8b6-f861-4db6-9fc0-5bea90d528e5">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-03-12" />
      <value currency="USD" value-date="2021-03-12">15879436.94</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d54f4440-5acd-4f27-90f5-cb1c87210c4d">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-03-26" />
      <value currency="USD" value-date="2021-03-26">8381062.73</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="9bd2524f-3993-49c5-afa6-5b634dfbabf9">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-04-01" />
      <value currency="USD" value-date="2021-04-01">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9a442208-9af5-47ad-9ad6-af385637b871">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-04-06" />
      <value currency="USD" value-date="2021-04-06">1096587.07</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="84d33648-88aa-4282-941f-2be53900ebd0">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-04-09" />
      <value currency="USD" value-date="2021-04-09">5988461.31</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ac2f95d9-88f6-4feb-9be5-2c6179454ec4">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-04-09" />
      <value currency="USD" value-date="2021-04-09">890609.85</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="8d15fc01-0ddb-400a-8b0c-839f75f08a18">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-04-09" />
      <value currency="USD" value-date="2021-04-09">593739.90</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="a3ca6f44-7317-412c-a74c-2bc0b51e5801">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-04-09" />
      <value currency="USD" value-date="2021-04-09">593739.90</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="3de2c8f8-deef-4bc2-9909-1a9565d35a0a">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-04-09" />
      <value currency="USD" value-date="2021-04-09">593739.90</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="8aa78dc7-8101-40dd-acc6-b8cb2e95b43f">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-05-07" />
      <value currency="USD" value-date="2021-05-07">34070144.83</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8a3e0996-669e-48a6-89e5-3d313608e879">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-06-10" />
      <value currency="USD" value-date="2021-06-10">-5988461.31</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1980a991-b3b4-4df9-a655-4138bfc381ba">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-06-10" />
      <value currency="USD" value-date="2021-06-10">6650887.92</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f0b1b68f-2e6a-44fe-9948-af23749b199c">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-06-23" />
      <value currency="USD" value-date="2021-06-23">6650887.92</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6cfe03ca-8464-486b-832d-4613ebaeb1c1">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-06-23" />
      <value currency="USD" value-date="2021-06-23">-6650887.92</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="84f1a532-0e3a-49d5-aaab-88a718ec4e78">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-06-28" />
      <value currency="USD" value-date="2021-06-28">57987.28</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="9f213335-d80d-4297-900b-ac158dc1eadb">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-06-28" />
      <value currency="USD" value-date="2021-06-28">6553.69</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="35bb2c84-ccc9-46dd-9745-c95c65146076">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-06-28" />
      <value currency="USD" value-date="2021-06-28">49059.99</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="66c49b3f-d403-4e58-95c6-ce54312373f6">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-07-13" />
      <value currency="USD" value-date="2021-07-13">50000.00</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="48072b57-89b6-4046-ab96-09a477b06a7f">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-07-20" />
      <value currency="USD" value-date="2021-07-20">-1250102.22</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0381b4ce-64d2-496a-91a3-01fac65ac8d5">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-07-20" />
      <value currency="USD" value-date="2021-07-20">22072334.78</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f46a1304-3961-4338-919d-baaabc76ff01">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-07-22" />
      <value currency="USD" value-date="2021-07-22">5275908.02</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="bd1a9d41-0090-449a-9109-5249b6a399d1">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-07-22" />
      <value currency="USD" value-date="2021-07-22">4627215.33</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8078a54b-e2aa-4d6d-9403-33787ce29533">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-07-22" />
      <value currency="USD" value-date="2021-07-22">7583661.64</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8b9947b0-a259-4dec-802c-34d88499e8ed">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-07-22" />
      <value currency="USD" value-date="2021-07-22">4585549.79</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ea8f2bab-c7d3-4cf9-a25e-da799af699fc">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-07-28" />
      <value currency="USD" value-date="2021-07-28">3211180.76</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="69d1d4ac-5a73-494b-8a71-cfacb6576269">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-08-30" />
      <value currency="USD" value-date="2021-08-30">37804.85</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="c08b8176-432f-4d11-a512-fb76cfa3cd94">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-09-17" />
      <value currency="USD" value-date="2021-09-17">37804.86</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="8083b646-59d5-423d-88b2-2f6d3d496346">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-09-17" />
      <value currency="USD" value-date="2021-09-17">2663843.35</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="2f23fa9c-9891-4c38-8791-8fde0837a819">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-09-17" />
      <value currency="USD" value-date="2021-09-17">41610.18</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="7594ad74-f818-4040-8337-dae3339d4c2e">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-08" />
      <value currency="USD" value-date="2021-10-08">-775863.81</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7c5b0618-52eb-48c5-9a50-d73bb3339df5">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-08" />
      <value currency="USD" value-date="2021-10-08">113437.20</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="36d64451-2a65-4510-a28e-ba1c37d49aa0">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-08" />
      <value currency="USD" value-date="2021-10-08">662426.61</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6d359923-36e5-4ce4-abce-a29a97b2a4db">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-12" />
      <value currency="USD" value-date="2021-10-12">26394580.00</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c387f164-ec5b-4c64-8ba6-511033739a65">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-12" />
      <value currency="USD" value-date="2021-10-12">-3499136.74</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="cd328472-19d6-4972-be10-0d86d7cfbc15">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-12" />
      <value currency="USD" value-date="2021-10-12">3536941.59</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3faf0d5f-5a98-44f3-9aa3-d469f613dd78">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-12" />
      <value currency="USD" value-date="2021-10-12">-37804.85</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ce17dedd-2180-4806-9ef7-6ca23a79dc8f">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-13" />
      <value currency="USD" value-date="2021-10-13">-3536941.59</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7a63d107-b4ed-4a29-84ea-e2af0287b980">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-13" />
      <value currency="USD" value-date="2021-10-13">-37804.86</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="03bbfb74-2817-4774-bfa3-4313bd151ce7">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-13" />
      <value currency="USD" value-date="2021-10-13">3574746.45</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8e4100e8-9b7a-44a1-83d7-908b0ac328aa">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-14" />
      <value currency="USD" value-date="2021-10-14">1132240.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a2670600-b035-4f82-b4d5-d47624a3b24e">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-14" />
      <value currency="USD" value-date="2021-10-14">1492183.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="add4cc5c-1bb4-4100-8dc0-003a9bee785c">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-14" />
      <value currency="USD" value-date="2021-10-14">17252711.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8b7172e7-4ffc-4cb5-8259-8a87aeaf46a8">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-14" />
      <value currency="USD" value-date="2021-10-14">1047720.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6a51a9e1-31e1-44b1-ac93-2c9036ad0d18">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-14" />
      <value currency="USD" value-date="2021-10-14">1415466.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5681bc93-4ef4-4f16-9482-e8f76f7d7e9a">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-14" />
      <value currency="USD" value-date="2021-10-14">2045205.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0d81a2c3-795d-470a-9ee1-e1f5f12b8034">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-14" />
      <value currency="USD" value-date="2021-10-14">15010.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="28731f95-71e5-408a-8402-7cfa1b7e561a">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-14" />
      <value currency="USD" value-date="2021-10-14">1994045.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f702175e-952c-4116-9acd-8d375fc11157">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-10-18" />
      <value currency="USD" value-date="2021-10-18">37804.85</value>
      <description>
        <narrative>Funds returned to the Global Fund from ZAF-C-NDOHP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ed691b30-6833-471c-a4d0-12025e04f724">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-10-18" />
      <value currency="USD" value-date="2021-10-18">37804.86</value>
      <description>
        <narrative>Funds returned to the Global Fund from ZAF-C-NDOHP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a8b67889-9a1c-4f51-8ad3-a199a7f23a36">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-19" />
      <value currency="USD" value-date="2021-10-19">-662426.61</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="bee5f924-1f21-49cd-bcc7-b8c21efda2f4">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-22" />
      <value currency="USD" value-date="2021-10-22">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7e578f6c-1a6a-419a-9e25-6407a07b5210">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-23" />
      <value currency="USD" value-date="2021-10-23">-113437.20</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="387f2219-b5e4-4328-86b1-ce9923c6925a">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-23" />
      <value currency="USD" value-date="2021-10-23">-76170.91</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="41e19e7d-8eec-42ca-ae65-4b927b391824">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-23" />
      <value currency="USD" value-date="2021-10-23">189608.11</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c86cf32a-0416-4242-aa6c-d905f528b24a">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-10-25" />
      <value currency="USD" value-date="2021-10-25">76170.91</value>
      <description>
        <narrative>Funds returned to the Global Fund from ZAF-C-NDOHP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="04730d86-3ed9-45d9-8352-e20f3ea6b375">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-11-04" />
      <value currency="USD" value-date="2021-11-04">15394.01</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="9ac2250e-c767-425d-ad65-ddab87412fdd">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-11-27" />
      <value currency="USD" value-date="2021-11-27">-189608.11</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d0a8a5a8-021c-4e01-a54b-73bc847f9518">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-12-07" />
      <value currency="USD" value-date="2021-12-07">52730199.50</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0068e261-5951-453b-be0e-7d8565bdf905">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-12-09" />
      <value currency="USD" value-date="2021-12-09">1943821.61</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c64b182f-3903-464b-855a-a2ffc5ffc321">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-12-09" />
      <value currency="USD" value-date="2021-12-09">1345299.45</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="bba7a91c-fbf4-4100-8cde-30c9a504b4f2">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-12-09" />
      <value currency="USD" value-date="2021-12-09">1895197.95</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8dfbfaf8-6868-40be-ac66-38198bb67178">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-12-09" />
      <value currency="USD" value-date="2021-12-09">995783.71</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="764f7860-f32b-4516-bd0a-7b6e01f87626">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-12-09" />
      <value currency="USD" value-date="2021-12-09">14266.10</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7bbd23da-3197-4720-a9ee-c94c6bc8dbc5">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-12-09" />
      <value currency="USD" value-date="2021-12-09">1418213.80</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="471d7a41-bd75-4f21-80c1-2fb1c61ea516">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-12-09" />
      <value currency="USD" value-date="2021-12-09">16397475.62</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2ce7a75b-429f-4214-9969-a1a97d044d91">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-12-09" />
      <value currency="USD" value-date="2021-12-09">1077545.17</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e1c0c8e0-1e0c-4f13-8580-914ffd2a8817">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-12-14" />
      <value currency="USD" value-date="2021-12-14">-3559352.44</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="00fd9d5c-268a-4d4d-baf9-035f1f371499">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-03-03" />
      <value currency="USD" value-date="2022-03-03">1349819.04</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="fd69fc18-5041-4c79-9d63-eae25f68c36d">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-03-03" />
      <value currency="USD" value-date="2022-03-03">2336310.56</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="dec9436d-5d37-4787-8ceb-89c9d44deb93">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-03-03" />
      <value currency="USD" value-date="2022-03-03">58618.28</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b3e51c87-fd93-4e5c-9c1d-fcd16fd649c4">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-03-03" />
      <value currency="USD" value-date="2022-03-03">1575180.68</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="640ab520-fba9-4a43-842c-76f780a9ed71">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-03-03" />
      <value currency="USD" value-date="2022-03-03">304343.08</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4688591e-26f5-4ffc-99df-35ef5088fde4">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-03-03" />
      <value currency="USD" value-date="2022-03-03">633448.36</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2d3525bf-0bb7-4cd6-b30c-a79219380d7f">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-03-03" />
      <value currency="USD" value-date="2022-03-03">3562733.71</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e62072dc-ea20-4ee0-a4f0-dcfa806297ab">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-05-19" />
      <value currency="USD" value-date="2022-05-19">366667.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c706d30f-d058-424b-96a2-d64021fec328">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-05-19" />
      <value currency="USD" value-date="2022-05-19">1383765.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="daea3ba7-7d41-41ab-b6e8-4a36c6d43028">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-05-19" />
      <value currency="USD" value-date="2022-05-19">779297.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4a53f14c-c967-417a-aa2d-a9f9874a6dc0">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-05-19" />
      <value currency="USD" value-date="2022-05-19">153333.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4e9c0b0b-9b8f-4740-9e0f-301cea718856">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-05-19" />
      <value currency="USD" value-date="2022-05-19">5813333.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="08b98af7-3161-4070-96c4-a4afd67e6cf8">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-05-19" />
      <value currency="USD" value-date="2022-05-19">1504558.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f5870806-2a11-4329-a694-31ad9033117c">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-02-24" />
      <value currency="USD" value-date="2023-02-24">-7821189.38</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="63a81099-dc14-42d1-923f-3aab428254d0">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-02-24" />
      <value currency="USD" value-date="2023-02-24">3068822.72</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="abd303f6-7f96-4f9e-aa9d-fd10d83849f2">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-03-11" />
      <value currency="USD" value-date="2024-03-11">-3068822.72</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="14ab754d-d509-4daf-9ad7-356440ba76c4">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-04-01" />
      <value currency="USD" value-date="2024-04-01">94214.43</value>
      <description>
        <narrative>Funds returned to the Global Fund from ZAF-C-NDOHP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0a02d81e-9ed7-48da-9dca-200a08e6b7f5">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-04-03" />
      <value currency="USD" value-date="2024-04-03">236654.03</value>
      <description>
        <narrative>Funds returned to the Global Fund from ZAF-C-NDOHP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d7b57ccc-1199-42fe-b8c5-106b6e6330c3">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-04-05" />
      <value currency="USD" value-date="2024-04-05">-236654.03</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2058636f-d5a5-4927-aa9c-2086b1c05ad4">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-04-05" />
      <value currency="USD" value-date="2024-04-05">-94214.43</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="82536eee-5c84-471f-89b6-f35981c41428">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-05-24" />
      <value currency="USD" value-date="2024-05-24">130722.09</value>
      <description>
        <narrative>Funds returned to the Global Fund from ZAF-C-NDOHP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ba9d1ec4-469d-477d-8b7d-2cf336a287cf">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-05-29" />
      <value currency="USD" value-date="2024-05-29">-130722.09</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="63d5aed2-fa61-4c7e-a887-a3d88661e496">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-08-04" />
      <value currency="USD" value-date="2025-08-04">2690383.58</value>
      <description>
        <narrative>Funds returned to the Global Fund from ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2f975399-92f3-4b5e-9e59-b08d5965016b">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-08-07" />
      <value currency="USD" value-date="2025-08-07">-2690383.58</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="de6d3e56-b157-4942-874d-d63260aa5fb1">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-09-16" />
      <value currency="USD" value-date="2025-09-16">3834.33</value>
      <description>
        <narrative>Funds returned to the Global Fund from ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e7f84221-965e-4e0f-8252-1259f8861ca9">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-09-22" />
      <value currency="USD" value-date="2025-09-22">-3834.33</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ZAF-C-NDOHP02-EXP-20200331">
      <transaction-type code="4" />
      <transaction-date iso-date="2020-03-31" />
      <value currency="USD" value-date="2020-03-31">20354805.00</value>
      <description>
        <narrative>Expenditure reported by National Department of Health of the Republic of South Africa for ZAF-C-NDOHP02, Apr 2019 to Mar 2020.</narrative>
      </description>
      <provider-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </provider-org>
    </transaction>
    <transaction ref="ZAF-C-NDOHP02-EXP-20210331">
      <transaction-type code="4" />
      <transaction-date iso-date="2021-03-31" />
      <value currency="USD" value-date="2021-03-31">72467129.39</value>
      <description>
        <narrative>Expenditure reported by National Department of Health of the Republic of South Africa for ZAF-C-NDOHP02, Apr 2020 to Mar 2021.</narrative>
      </description>
      <provider-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </provider-org>
    </transaction>
    <transaction ref="ZAF-C-NDOHP02-EXP-20220331">
      <transaction-type code="4" />
      <transaction-date iso-date="2022-03-31" />
      <value currency="USD" value-date="2022-03-31">128279357.37</value>
      <description>
        <narrative>Expenditure reported by National Department of Health of the Republic of South Africa for ZAF-C-NDOHP02, Apr 2021 to Mar 2022.</narrative>
      </description>
      <provider-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </provider-org>
    </transaction>
    <transaction ref="ZAF-C-NDOHP02-EXP-20220930">
      <transaction-type code="4" />
      <transaction-date iso-date="2022-09-30" />
      <value currency="USD" value-date="2022-09-30">-7554134.45</value>
      <description>
        <narrative>Expenditure reported by National Department of Health of the Republic of South Africa for ZAF-C-NDOHP02, Apr 2022 to Sep 2022.</narrative>
      </description>
      <provider-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/ZAF-C-NDOH" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-10" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="5394" />
        <period>
          <period-start iso-date="2019-04-01" />
          <period-end iso-date="2019-09-30" />
          <target value="3042" />
          <actual value="2859" />
        </period>
        <period>
          <period-start iso-date="2019-10-01" />
          <period-end iso-date="2020-03-31" />
          <target value="3042" />
          <actual value="2827" />
        </period>
        <period>
          <period-start iso-date="2020-04-01" />
          <period-end iso-date="2020-09-30" />
          <target value="3147" />
          <actual value="2216" />
        </period>
        <period>
          <period-start iso-date="2020-10-01" />
          <period-end iso-date="2021-03-31" />
          <target value="3147" />
          <actual value="1958" />
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2022-03-31" />
          <target value="7990" />
          <actual value="4193" />
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2021-09-30" />
          <target value="3628" />
          <actual value="2049" />
        </period>
        <period>
          <period-start iso-date="2021-10-01" />
          <period-end iso-date="2022-03-31" />
          <target value="4362" />
          <actual value="2144" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="5133" />
        <period>
          <period-start iso-date="2019-04-01" />
          <period-end iso-date="2019-09-30" />
          <target value="2737" />
          <actual value="1711" />
        </period>
        <period>
          <period-start iso-date="2019-10-01" />
          <period-end iso-date="2020-03-31" />
          <target value="2737" />
          <actual value="2054" />
        </period>
        <period>
          <period-start iso-date="2020-04-01" />
          <period-end iso-date="2020-09-30" />
          <target value="2832" />
          <actual value="1721" />
        </period>
        <period>
          <period-start iso-date="2020-10-01" />
          <period-end iso-date="2021-03-31" />
          <target value="2832" />
          <actual value="1391" />
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2021-09-30" />
          <target value="3265" />
          <actual value="1591" />
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2022-03-31" />
          <target value="7189" />
          <actual value="3160" />
        </period>
        <period>
          <period-start iso-date="2021-10-01" />
          <period-end iso-date="2022-03-31" />
          <target value="3924" />
          <actual value="1569" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Health management information systems and M&amp;E.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2018" iso-date="2018-12-31" value="99.12">
          <comment>
            <narrative>Numerator: 4819; Denominator: 4862.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-04-01" />
          <period-end iso-date="2019-09-30" />
          <target value="99">
            <comment>
              <narrative>Numerator: 4170; Denominator: 4212.</narrative>
            </comment>
          </target>
          <actual value="99.6">
            <comment>
              <narrative>Numerator: 4253; Denominator: 4271.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-10-01" />
          <period-end iso-date="2020-03-31" />
          <target value="99.37">
            <comment>
              <narrative>Numerator: 4890; Denominator: 4921.</narrative>
            </comment>
          </target>
          <actual value="98.8">
            <comment>
              <narrative>Numerator: 4881; Denominator: 4941.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-04-01" />
          <period-end iso-date="2020-09-30" />
          <target value="99.37">
            <comment>
              <narrative>Numerator: 4890; Denominator: 4921.</narrative>
            </comment>
          </target>
          <actual value="96.7">
            <comment>
              <narrative>Numerator: 4655; Denominator: 4815.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-10-01" />
          <period-end iso-date="2021-03-31" />
          <target value="99.37">
            <comment>
              <narrative>Numerator: 4890; Denominator: 4921.</narrative>
            </comment>
          </target>
          <actual value="99.1">
            <comment>
              <narrative>Numerator: 4730; Denominator: 4774.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2022-03-31" />
          <target value="99.4">
            <comment>
              <narrative>Numerator: 9780; Denominator: 9842.</narrative>
            </comment>
          </target>
          <actual value="99">
            <comment>
              <narrative>Numerator: 9477; Denominator: 9574.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2021-09-30" />
          <target value="99.4">
            <comment>
              <narrative>Numerator: 4890; Denominator: 4921.</narrative>
            </comment>
          </target>
          <actual value="99.1">
            <comment>
              <narrative>Numerator: 4743; Denominator: 4785.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-10-01" />
          <period-end iso-date="2022-03-31" />
          <target value="99.4">
            <comment>
              <narrative>Numerator: 4890; Denominator: 4921.</narrative>
            </comment>
          </target>
          <actual value="98.9">
            <comment>
              <narrative>Numerator: 4734; Denominator: 4789.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of children &lt;5 in contact with TB patients who began isonizide preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of children &lt;5 in contact with TB patients who began isonizide preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="12883" />
        <period>
          <period-start iso-date="2019-04-01" />
          <period-end iso-date="2019-09-30" />
          <target value="7730" />
          <actual value="5173" />
        </period>
        <period>
          <period-start iso-date="2019-10-01" />
          <period-end iso-date="2020-03-31" />
          <target value="7730" />
          <actual value="4855" />
        </period>
        <period>
          <period-start iso-date="2020-04-01" />
          <period-end iso-date="2020-09-30" />
          <target value="9018" />
          <actual value="2335" />
        </period>
        <period>
          <period-start iso-date="2020-10-01" />
          <period-end iso-date="2021-03-31" />
          <target value="9018" />
          <actual value="3568" />
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2021-09-30" />
          <target value="11464" />
          <actual value="5891" />
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2022-03-31" />
          <target value="25242" />
          <actual value="12116" />
        </period>
        <period>
          <period-start iso-date="2021-10-01" />
          <period-end iso-date="2022-03-31" />
          <target value="13778" />
          <actual value="6225" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="83699" />
        <period>
          <period-start iso-date="2019-04-01" />
          <period-end iso-date="2019-09-30" />
          <target value="39063" />
          <actual value="32485" />
        </period>
        <period>
          <period-start iso-date="2019-10-01" />
          <period-end iso-date="2020-03-31" />
          <target value="61036" />
          <actual value="47616" />
        </period>
        <period>
          <period-start iso-date="2020-04-01" />
          <period-end iso-date="2020-09-30" />
          <target value="52550" />
          <actual value="31441" />
        </period>
        <period>
          <period-start iso-date="2020-10-01" />
          <period-end iso-date="2021-03-31" />
          <target value="52550" />
          <actual value="36398" />
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2022-03-31" />
          <target value="135029" />
          <actual value="87817" />
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2021-09-30" />
          <target value="61326" />
          <actual value="41319" />
        </period>
        <period>
          <period-start iso-date="2021-10-01" />
          <period-end iso-date="2022-03-31" />
          <target value="73703" />
          <actual value="46498" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="83.4">
          <comment>
            <narrative>Numerator: 79142; Denominator: 94896.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2020-04-01" />
          <period-end iso-date="2020-09-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 35157; Denominator: 39063.</narrative>
            </comment>
          </target>
          <actual value="79.3">
            <comment>
              <narrative>Numerator: 30274; Denominator: 38161.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-10-01" />
          <period-end iso-date="2021-03-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 54932; Denominator: 61035.</narrative>
            </comment>
          </target>
          <actual value="79.4">
            <comment>
              <narrative>Numerator: 35711; Denominator: 44994.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2021-09-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 47295; Denominator: 52549.</narrative>
            </comment>
          </target>
          <actual value="79">
            <comment>
              <narrative>Numerator: 28341; Denominator: 35880.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2022-03-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 94590; Denominator: 105098.</narrative>
            </comment>
          </target>
          <actual value="78.9">
            <comment>
              <narrative>Numerator: 54498; Denominator: 69031.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-10-01" />
          <period-end iso-date="2022-03-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 47295; Denominator: 52549.</narrative>
            </comment>
          </target>
          <actual value="78.9">
            <comment>
              <narrative>Numerator: 26157; Denominator: 33151.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="87.03">
          <comment>
            <narrative>Numerator: 41302; Denominator: 47457.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-04-01" />
          <period-end iso-date="2019-09-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 19934; Denominator: 22148.</narrative>
            </comment>
          </target>
          <actual value="62.6">
            <comment>
              <narrative>Numerator: 13133; Denominator: 20993.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-10-01" />
          <period-end iso-date="2020-03-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 31146; Denominator: 34607.</narrative>
            </comment>
          </target>
          <actual value="84.5">
            <comment>
              <narrative>Numerator: 22692; Denominator: 26859.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-04-01" />
          <period-end iso-date="2020-09-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 26816; Denominator: 29795.</narrative>
            </comment>
          </target>
          <actual value="84">
            <comment>
              <narrative>Numerator: 16457; Denominator: 19583.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-10-01" />
          <period-end iso-date="2021-03-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 26816; Denominator: 29795.</narrative>
            </comment>
          </target>
          <actual value="85">
            <comment>
              <narrative>Numerator: 15623; Denominator: 18376.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2022-03-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 72916; Denominator: 81018.</narrative>
            </comment>
          </target>
          <actual value="89.1">
            <comment>
              <narrative>Numerator: 39368; Denominator: 44177.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2021-09-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 33116; Denominator: 36796.</narrative>
            </comment>
          </target>
          <actual value="88.5">
            <comment>
              <narrative>Numerator: 18611; Denominator: 21033.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-10-01" />
          <period-end iso-date="2022-03-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 39800; Denominator: 44222.</narrative>
            </comment>
          </target>
          <actual value="89.7">
            <comment>
              <narrative>Numerator: 20757; Denominator: 23144.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV newly enrolled in HIV care started on TB preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV newly enrolled in HIV care started on TB preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="56.27">
          <comment>
            <narrative>Numerator: 177742; Denominator: 315890.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-04-01" />
          <period-end iso-date="2019-09-30" />
          <target value="66.82">
            <comment>
              <narrative>Numerator: 150535; Denominator: 225296.</narrative>
            </comment>
          </target>
          <actual value="90.2">
            <comment>
              <narrative>Numerator: 128419; Denominator: 142332.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-10-01" />
          <period-end iso-date="2020-03-31" />
          <target value="66.82">
            <comment>
              <narrative>Numerator: 150535; Denominator: 225296.</narrative>
            </comment>
          </target>
          <actual value="92.1">
            <comment>
              <narrative>Numerator: 121304; Denominator: 131707.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-04-01" />
          <period-end iso-date="2020-09-30" />
          <target value="78">
            <comment>
              <narrative>Numerator: 175731; Denominator: 225296.</narrative>
            </comment>
          </target>
          <actual value="93.6">
            <comment>
              <narrative>Numerator: 71975; Denominator: 76905.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-10-01" />
          <period-end iso-date="2021-03-31" />
          <target value="78">
            <comment>
              <narrative>Numerator: 175731; Denominator: 225296.</narrative>
            </comment>
          </target>
          <actual value="93.9">
            <comment>
              <narrative>Numerator: 82087; Denominator: 87403.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2022-03-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 405532; Denominator: 450592.</narrative>
            </comment>
          </target>
          <actual value="92.4">
            <comment>
              <narrative>Numerator: 143306; Denominator: 155045.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2021-09-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 202766; Denominator: 225296.</narrative>
            </comment>
          </target>
          <actual value="94.3">
            <comment>
              <narrative>Numerator: 77406; Denominator: 82077.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-10-01" />
          <period-end iso-date="2022-03-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 202766; Denominator: 225296.</narrative>
            </comment>
          </target>
          <actual value="90.3">
            <comment>
              <narrative>Numerator: 65900; Denominator: 72968.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="94.79">
          <comment>
            <narrative>Numerator: 79342; Denominator: 83699.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-04-01" />
          <period-end iso-date="2019-09-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 39063; Denominator: 39063.</narrative>
            </comment>
          </target>
          <actual value="49.3">
            <comment>
              <narrative>Numerator: 20993; Denominator: 42612.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-10-01" />
          <period-end iso-date="2020-03-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 61036; Denominator: 61035.</narrative>
            </comment>
          </target>
          <actual value="87.8">
            <comment>
              <narrative>Numerator: 41581; Denominator: 47345.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-04-01" />
          <period-end iso-date="2020-09-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 52550; Denominator: 52549.</narrative>
            </comment>
          </target>
          <actual value="79.4">
            <comment>
              <narrative>Numerator: 30130; Denominator: 37939.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-10-01" />
          <period-end iso-date="2021-03-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 52550; Denominator: 52549.</narrative>
            </comment>
          </target>
          <actual value="76.8">
            <comment>
              <narrative>Numerator: 28672; Denominator: 37355.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2022-03-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 135029; Denominator: 135029.</narrative>
            </comment>
          </target>
          <actual value="88.4">
            <comment>
              <narrative>Numerator: 75631; Denominator: 85585.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2021-09-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 61326; Denominator: 61326.</narrative>
            </comment>
          </target>
          <actual value="87.3">
            <comment>
              <narrative>Numerator: 34501; Denominator: 39530.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-10-01" />
          <period-end iso-date="2022-03-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 73703; Denominator: 73703.</narrative>
            </comment>
          </target>
          <actual value="89.3">
            <comment>
              <narrative>Numerator: 41130; Denominator: 46055.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV currently receiving antiretroviral therapy</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV currently receiving antiretroviral therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="59.45">
          <comment>
            <narrative>Numerator: 4189070; Denominator: 7046301.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31" value="58">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2017" iso-date="2017-12-31" value="58">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2017" iso-date="2017-12-31" value="58">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2017" iso-date="2017-12-31" value="58">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2017" iso-date="2017-12-31" value="58">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2017" iso-date="2017-12-31" value="60">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2017" iso-date="2017-12-31" value="60">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2017" iso-date="2017-12-31" value="60">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2017" iso-date="2017-12-31" value="60">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2017" iso-date="2017-12-31" value="60">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <period>
          <period-start iso-date="2019-04-01" />
          <period-end iso-date="2019-09-30" />
          <target value="70.52">
            <comment>
              <narrative>Numerator: 5400000; Denominator: 7656920.</narrative>
            </comment>
          </target>
          <actual value="63.4">
            <comment>
              <narrative>Numerator: 4855841; Denominator: 7656920.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-10-01" />
          <period-end iso-date="2020-03-31" />
          <target value="75.75">
            <comment>
              <narrative>Numerator: 5800000; Denominator: 7656920.</narrative>
            </comment>
          </target>
          <actual value="65.5">
            <comment>
              <narrative>Numerator: 5015476; Denominator: 7656920.</narrative>
            </comment>
          </actual>
          <actual value="66.8">
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 4866991; Denominator: 7280359.</narrative>
            </comment>
          </actual>
          <actual value="46.6">
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 148485; Denominator: 318856.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-04-01" />
          <period-end iso-date="2020-09-30" />
          <target value="76.45">
            <comment>
              <narrative>Numerator: 5950000; Denominator: 7782830.</narrative>
            </comment>
          </target>
          <actual value="63.6">
            <comment>
              <narrative>Numerator: 4948925; Denominator: 7782830.</narrative>
            </comment>
          </actual>
          <actual value="61.8">
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 4806662; Denominator: 7782830.</narrative>
            </comment>
          </actual>
          <actual value="1.8">
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 142263; Denominator: 7782830.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-10-01" />
          <period-end iso-date="2021-03-31" />
          <target value="78.38">
            <comment>
              <narrative>Numerator: 6100000; Denominator: 7782830.</narrative>
            </comment>
          </target>
          <actual value="65.7">
            <comment>
              <narrative>Numerator: 5115943; Denominator: 7782830.</narrative>
            </comment>
          </actual>
          <actual value="64">
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 4979284; Denominator: 7782830.</narrative>
            </comment>
          </actual>
          <actual value="1.8">
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 136659; Denominator: 7782830.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2021-09-30" />
          <target value="78.5">
            <comment>
              <narrative>Numerator: 6200000; Denominator: 7899150.</narrative>
            </comment>
          </target>
          <actual value="66.1">
            <comment>
              <narrative>Numerator: 5222838; Denominator: 7899150.</narrative>
            </comment>
          </actual>
          <actual value="64.25">
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 5075226; Denominator: 7899150.</narrative>
            </comment>
          </actual>
          <actual value="1.66">
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 130876; Denominator: 7899150.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2022-03-31" />
          <target value="79.8">
            <comment>
              <narrative>Numerator: 6300000; Denominator: 7899150.</narrative>
            </comment>
          </target>
          <actual value="66.7">
            <comment>
              <narrative>Numerator: 5271837; Denominator: 7899150.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-10-01" />
          <period-end iso-date="2022-03-31" />
          <target value="79.8">
            <comment>
              <narrative>Numerator: 6300000; Denominator: 7899150.</narrative>
            </comment>
          </target>
          <actual value="66.7">
            <comment>
              <narrative>Numerator: 5271837; Denominator: 7899150.</narrative>
            </comment>
          </actual>
          <actual value="72.95">
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 5148698; Denominator: 7058030.</narrative>
            </comment>
          </actual>
          <actual value="51.69">
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 123139; Denominator: 238244.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-10T16:44:39+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-ZAF-C-NDOH-3</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Investing for impact against Tuberculosis and HIV - South Africa (01-Apr-2022-30-Sep-2025)</narrative>
    </title>
    <description type="1">
      <narrative>South Africa, TB/HIV, National Department of Health of the Republic of South Africa</narrative>
    </description>
    <description type="2">
      <narrative>Goals: Accelerate prevention to reduce new HIV and TB infections and STIs; Reduce morbidity and mortality by providing treatment, care and adherence support for all; Ground the response to HIV, TB and STIs in human rights principles and approaches; Promote leadership and shared accountability for sustainable response to HIV, TB and STIs; Mobilise resources and maximise efficiencies to support the achievment of NSP goals and ensure a sustainable approach; Strengthen strategic information to drive progress towards achievement of NSP goals. Objectives: Implement the 95-95-95 Strategy for TB; Increase engagment, collaboration and advocacy of key and vulnerable populations in the development and implementation of social and health support activities; To provide an enabling environment to increase access to health services by key and vulnerable populations; Promote an environment that enables and protects human and legal rights and prevents stigma and discrimination; Strengthen AIDS Councils to provide effective co-ordination and leadership of all stakeholders for shared accountability in the implementation of the NSP; Improve efficiency and mobilise sufficient resources to achieve the goals, objective and targets of the NSP; Optimise routinely collected strategic health information for data utilisation in decision making.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="10" role="2" crs-channel-code="12001">
      <narrative>National Department of Health of the Republic of South Africa</narrative>
    </participating-org>
    <participating-org type="10" role="4" crs-channel-code="12001">
      <narrative>National Department of Health of the Republic of South Africa</narrative>
    </participating-org>
    <other-identifier ref="ZAF-C-NDOHP03" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="3" />
    <activity-date type="1" iso-date="2022-04-01" />
    <activity-date type="2" iso-date="2022-04-01" />
    <activity-date type="3" iso-date="2025-09-30" />
    <activity-date type="4" iso-date="2025-09-30" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>John Ochero</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>john.ochero@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="ZA" percentage="100">
      <narrative>South Africa</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="45.59">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="13040" percentage="36.18">
      <narrative>HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="18.23">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="67b7abf2-42e5-4cc4-b75d-4eb6ea4f22b4" percentage="1.01">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Self-testing</narrative>
        </description>
      </budget-item>
      <budget-item code="56595a18-f1ed-4f39-8c05-d687d5911e6b" percentage="0.93">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Human rights and medical ethics related to HIV and HIV/TB for health care providers</narrative>
        </description>
      </budget-item>
      <budget-item code="336e2f1a-7395-4d59-b42e-5e9916975074" percentage="0.01">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Counseling and psycho-social support</narrative>
        </description>
      </budget-item>
      <budget-item code="b0eb178f-7923-4f1d-a0dc-04aed075b79a" percentage="34.23">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Differentiated ART service delivery and HIV care</narrative>
        </description>
      </budget-item>
      <budget-item code="31a8e187-9648-42f5-a520-92e7e53d4ac6" percentage="12.05">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="a459608e-6d6a-4392-8e91-a6ce763883ca" percentage="0.63">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-based monitoring</narrative>
        </description>
      </budget-item>
      <budget-item code="ea41b061-34f4-4f5f-b2d7-d7e7838c9c59" percentage="0.18">
        <description>
          <narrative>RSSH -&gt; RSSH: Financial management systems -&gt; Routine grant financial management</narrative>
        </description>
      </budget-item>
      <budget-item code="c9e8bc4a-398e-4c4b-afbb-cf98965f552e" percentage="0.01">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Analysis, evaluations, reviews and transparency</narrative>
        </description>
      </budget-item>
      <budget-item code="7d2483ee-e340-40e2-8f81-88b761c385aa" percentage="2.15">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="cc2a3288-298b-4e87-9cd4-3b8c1601d54c" percentage="0.15">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Policy, strategy, governance</narrative>
        </description>
      </budget-item>
      <budget-item code="45f58950-e70b-425c-a83d-28115a57a936" percentage="1.76">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Regulatory/quality assurance support</narrative>
        </description>
      </budget-item>
      <budget-item code="73afa0ce-d818-4bb2-adeb-c13f28c03a1f" percentage="0.25">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Storage and distribution capacity</narrative>
        </description>
      </budget-item>
      <budget-item code="4078713e-8351-4887-be1a-1617bf48ccd5" percentage="0.06">
        <description>
          <narrative>RSSH -&gt; RSSH: Health sector governance and planning -&gt; National health sector strategies and financing</narrative>
        </description>
      </budget-item>
      <budget-item code="2c422db1-945a-4222-b6eb-8ea39fbf434f" percentage="0.27">
        <description>
          <narrative>RSSH -&gt; RSSH: Laboratory systems -&gt; Information systems and integrated specimen transport networks</narrative>
        </description>
      </budget-item>
      <budget-item code="ca59d83d-94c4-4f56-93fe-88d1caf39c5a" percentage="0.37">
        <description>
          <narrative>RSSH -&gt; RSSH: Laboratory systems -&gt; Infrastructure and equipment management systems</narrative>
        </description>
      </budget-item>
      <budget-item code="0651e028-d13e-4937-8777-a97183a5b108" percentage="0.05">
        <description>
          <narrative>RSSH -&gt; RSSH: Laboratory systems -&gt; Laboratory supply chain systems</narrative>
        </description>
      </budget-item>
      <budget-item code="951569a8-a591-40fc-9492-c7eb2322279f" percentage="0.3">
        <description>
          <narrative>RSSH -&gt; RSSH: Laboratory systems -&gt; National laboratory governance and management structures</narrative>
        </description>
      </budget-item>
      <budget-item code="9a89bb7c-0497-4574-b9d1-dd46b1823c81" percentage="0.09">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Engaging all care providers (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="8194063f-1bf8-4be2-9ebd-2823d5ac44a3" percentage="5.05">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="b108d9bd-d341-43a6-a473-1be4efabc458" percentage="0.49">
        <description>
          <narrative>Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Stigma and discrimination reduction (TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="a93b0a8f-4b2d-4b43-806e-06b2f2240144" percentage="25.46">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="2695e028-456c-4ded-83a4-ded520ff9d79" percentage="0.07">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Community TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="e5d69248-af9e-44de-a99d-c2557c675f55" percentage="0.25">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Engaging all care providers (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="3ec9daf3-963a-4853-8e5f-65867d3e7630" percentage="0.48">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Prevention (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="2b47e4dd-6430-4bc5-829c-127bb93a72a8" percentage="0">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="3844a48b-ee6f-484c-866d-4d19de42ce72" percentage="12.72">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; Community TB/HIV care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="f9ff8a94-1fc1-4acf-863f-a191df107ee9" percentage="0.14">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; Engaging all care providers (TB/HIV)</narrative>
        </description>
      </budget-item>
      <budget-item code="d5851297-913c-4ce3-a373-c0915334727a" percentage="0.43">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Prevention</narrative>
        </description>
      </budget-item>
      <budget-item code="31f7c6af-8b6f-4289-90f3-c6f20f232eb7" percentage="0.41">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Screening, testing and diagnosis</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2022-01-01" />
      <period-end iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-01-01">27369090.42</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2023-01-01" />
      <period-end iso-date="2023-12-31" />
      <value currency="USD" value-date="2023-01-01">80764824.59</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2024-01-01" />
      <period-end iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-01-01">177676544.98</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">99197719.66</value>
    </budget>
    <capital-spend percentage="12.64" />
    <transaction ref="39dc4de7-d4e5-46a8-b2c8-55deef2050ab">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-07-11" />
      <value currency="USD" value-date="2022-07-11">119390576.00</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="67a120c3-9155-47be-b16c-e579e77f48a5">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-07-14" />
      <value currency="USD" value-date="2022-07-14">3341293.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c4e02ed4-b465-4521-80c6-13a0e2288f0f">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-08-25" />
      <value currency="USD" value-date="2022-08-25">987226.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3e51f6c6-1f86-4301-9267-7cfca107da3b">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-08-25" />
      <value currency="USD" value-date="2022-08-25">2787881.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5e3a45ab-a0cc-400a-a7b7-88c7902398fb">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-08-25" />
      <value currency="USD" value-date="2022-08-25">1494778.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c4a3a7e0-f76f-4965-8687-f9d4b64d1777">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-09-22" />
      <value currency="USD" value-date="2022-09-22">354235.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="757c1cc8-7ef7-4d15-9ce5-b39ae66333d8">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-09-24" />
      <value currency="USD" value-date="2022-09-24">2151479.20</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d4189b19-eb9a-4a02-b489-6c973ba17676">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-12-01" />
      <value currency="USD" value-date="2022-12-01">12989222.17</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="64d45418-37a5-4d64-afd3-6b9833e9733c">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-12-01" />
      <value currency="USD" value-date="2022-12-01">32013.32</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="82652e39-fe22-4fea-bae0-95fb1514d066">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-12-01" />
      <value currency="USD" value-date="2022-12-01">47383.44</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="17a685da-2b5c-4e63-a863-e73c72b67c3e">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-12-01" />
      <value currency="USD" value-date="2022-12-01">1253961.12</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="24ea466e-bdc1-48d9-8ba3-613a3e1ef70e">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-12-01" />
      <value currency="USD" value-date="2022-12-01">10258154.38</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="80e77f5f-83db-4cc1-b713-0db578d62b72">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-12-01" />
      <value currency="USD" value-date="2022-12-01">2086986.29</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="a9dd711f-8a91-495a-8a5b-15d1da69294c">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-12-20" />
      <value currency="USD" value-date="2022-12-20">2440804.84</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9d8f032a-e991-4d9b-9999-8c4da6d8200e">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-02-01" />
      <value currency="USD" value-date="2023-02-01">-64492.91</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0dd8077a-2684-4c59-b7f5-b860f4a0a7e5">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-04-20" />
      <value currency="USD" value-date="2023-04-20">9064633.02</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="557c2c9a-92e4-416a-8756-c051d17b224c">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-04-20" />
      <value currency="USD" value-date="2023-04-20">36166653.37</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="fdf72cd2-dcbf-46a6-81f4-75f18befeaef">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-10-26" />
      <value currency="USD" value-date="2023-10-26">32544539.35</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6fb7e532-c194-4cbf-94fe-fbb6ea1ad45e">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-10-26" />
      <value currency="USD" value-date="2023-10-26">5627797.99</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="06c815de-60e0-4a03-af8e-4f37ecf30c87">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-03-21" />
      <value currency="USD" value-date="2024-03-21">50000.00</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="94daefee-2c35-486c-bed0-1ece170babda">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-04-11" />
      <value currency="USD" value-date="2024-04-11">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="bc655b28-3f6d-4975-9e33-73b2a9edeec3">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-06-06" />
      <value currency="USD" value-date="2024-06-06">178757615.98</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2438494a-bb16-4d8a-a499-19dec11bf6a9">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-06-11" />
      <value currency="USD" value-date="2024-06-11">29755298.60</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2602493f-3315-427e-af20-0f6ad9b2c597">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-09-17" />
      <value currency="USD" value-date="2024-09-17">22629798.35</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a6364576-715b-462b-a84a-54a4b5f40153">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-12-31">9512036.36</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ce6d139b-abeb-4f36-8413-b9f983dd773d">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-12-31">17466735.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="aaebb661-0010-4625-b3bb-07a0b67d1395">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-05-01" />
      <value currency="USD" value-date="2025-05-01">147331.70</value>
      <description>
        <narrative>Funds returned to the Global Fund from ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6130cc54-7bd7-4a39-923e-5668d99e2408">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-05-02" />
      <value currency="USD" value-date="2025-05-02">-147331.70</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2a9f9cbc-c565-4ad2-ae9c-76752792f334">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-10-03" />
      <value currency="USD" value-date="2025-10-03">88194390.00</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5fdc0e35-3797-4148-858c-9e07c7af9573">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-10-03" />
      <value currency="USD" value-date="2025-10-03">-56705855.45</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="53bda657-7228-4f62-9d53-2ffa4a4d4d10">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-10-07" />
      <value currency="USD" value-date="2025-10-07">34356358.96</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8a715fac-a1a4-4320-8200-9765b303e1bf">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-12-01" />
      <value currency="USD" value-date="2025-12-01">22851026.45</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4c4b8ec3-bfdb-4b21-903a-b048596085a9">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-12-01" />
      <value currency="USD" value-date="2025-12-01">18822912.55</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1c0f167a-c072-409d-bf59-034d668a0210">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-12-01" />
      <value currency="USD" value-date="2025-12-01">1013953.22</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="118a4734-cfeb-4309-a7cb-a3a8b196792c">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-04-17" />
      <value currency="USD" value-date="2026-04-17">2294878.75</value>
      <description>
        <narrative>Funds returned to the Global Fund from ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4333222c-20c7-48e7-97e4-482ff22d302c">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-24" />
      <value currency="USD" value-date="2026-04-24">-2294878.75</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="53428341-7ee3-48f0-ba4d-0b5f1c9ee461">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-07-10" />
      <value currency="USD" value-date="2026-07-10">121772.43</value>
      <description>
        <narrative>Funds returned to the Global Fund from ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4e8dde4a-3784-4a36-886a-2ecfd5e2d56d">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-07-15" />
      <value currency="USD" value-date="2026-07-15">-121772.43</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="aaffa4fa-1a78-4924-89eb-08afe87b0909">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-09-23" />
      <value currency="USD" value-date="2026-09-23">10842684.68</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d76f4c8c-b94f-408f-ba13-8280929b4a82">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-09-23" />
      <value currency="USD" value-date="2026-09-23">-53838031.04</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8434f638-c4c1-4459-bc57-d6ef444e09ed">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-09-29" />
      <value currency="USD" value-date="2026-09-29">10842684.68</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1389beeb-7b80-429d-b182-8c315128603c">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-11-01" />
      <value currency="USD" value-date="2026-11-01">297451.16</value>
      <description>
        <narrative>Funds returned to the Global Fund from ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="683f5d9d-28c1-48df-9701-830f0b6050f1">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-11-06" />
      <value currency="USD" value-date="2026-11-06">-297451.16</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ZAF-C-NDOHP03-EXP-20230331">
      <transaction-type code="4" />
      <transaction-date iso-date="2023-03-31" />
      <value currency="USD" value-date="2023-03-31">59526742.92</value>
      <description>
        <narrative>Expenditure reported by National Department of Health of the Republic of South Africa for ZAF-C-NDOHP03, Apr 2022 to Mar 2023.</narrative>
      </description>
      <provider-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </provider-org>
    </transaction>
    <transaction ref="ZAF-C-NDOHP03-EXP-20240331">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-03-31" />
      <value currency="USD" value-date="2024-03-31">74126910.64</value>
      <description>
        <narrative>Expenditure reported by National Department of Health of the Republic of South Africa for ZAF-C-NDOHP03, Apr 2023 to Mar 2024.</narrative>
      </description>
      <provider-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/ZAF-C-NDOH" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-10" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/ZAF/2021/TB_HIV/en/ZAF-C_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2021 - Funding Request - Window 6 - TB/HIV - South Africa - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1042-ZAF-C.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2021-09-10" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of PSA plants installed with Global Fund investments and functional</narrative>
      </title>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of PSA plants installed with Global Fund investments and functional</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31">
          <comment>
            <narrative>Numerator: 0; Denominator: 0; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 62.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2025-12-31" />
          <actual>
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of service delivery reports from community health units integrated/interoperable with the national HMIS</narrative>
      </title>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of service delivery reports from community health units integrated/interoperable with the national HMIS</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="100">
          <comment>
            <narrative>Numerator: 42; Denominator: 42.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-03-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 71; Denominator: 71.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 71; Denominator: 71.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 42; Denominator: 42.</narrative>
            </comment>
          </target>
          <actual value="97.62">
            <comment>
              <narrative>Numerator: 41; Denominator: 42.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 46; Denominator: 46.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2025-12-31" />
          <actual value="97.62">
            <comment>
              <narrative>Numerator: 41; Denominator: 42.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="4647" />
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2023-03-31" />
          <target value="4669" />
          <actual value="4104" />
        </period>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2022-09-30" />
          <target value="2334" />
          <actual value="2238" />
        </period>
        <period>
          <period-start iso-date="2022-10-01" />
          <period-end iso-date="2023-03-31" />
          <target value="2335" />
          <actual value="1866" />
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2024-03-31" />
          <target value="4802" />
          <actual value="3942" />
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2023-09-30" />
          <target value="2401" />
          <actual value="1729" />
        </period>
        <period>
          <period-start iso-date="2023-10-01" />
          <period-end iso-date="2024-03-31" />
          <target value="2401" />
          <actual value="2213" />
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target value="2508" />
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target value="5016" />
          <actual value="4199" />
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target value="2508" />
          <actual value="2036" />
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target value="2363" />
          <actual value="1918" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31">
          <comment>
            <narrative>Numerator: 3457.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3518; Denominator: 3635; Percentage: 96.78%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3518; Denominator: 3635; Percentage: 96.78%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3518; Denominator: 3635; Percentage: 96.78%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3518; Denominator: 3635; Percentage: 96.78%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3518; Denominator: 3635; Percentage: 96.78%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3518; Denominator: 3635; Percentage: 96.78%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 117; Denominator: 3635; Percentage: 3.22%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 117; Denominator: 3635; Percentage: 3.22%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 117; Denominator: 3635; Percentage: 3.22%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 117; Denominator: 3635; Percentage: 3.22%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 117; Denominator: 3635; Percentage: 3.22%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 117; Denominator: 3635; Percentage: 3.22%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1488; Denominator: 3635; Percentage: 40.94%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1488; Denominator: 3635; Percentage: 40.94%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1488; Denominator: 3635; Percentage: 40.94%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1488; Denominator: 3635; Percentage: 40.94%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1488; Denominator: 3635; Percentage: 40.94%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1488; Denominator: 3635; Percentage: 40.94%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 2147; Denominator: 3635; Percentage: 59.06%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 2147; Denominator: 3635; Percentage: 59.06%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 2147; Denominator: 3635; Percentage: 59.06%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 2147; Denominator: 3635; Percentage: 59.06%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 2147; Denominator: 3635; Percentage: 59.06%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 2147; Denominator: 3635; Percentage: 59.06%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="TB regimen" value="New TB drugs" />
          <comment>
            <narrative>Numerator: 3486; Denominator: 3635; Percentage: 95.9%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="TB regimen" value="New TB drugs" />
          <comment>
            <narrative>Numerator: 3486; Denominator: 3635; Percentage: 95.9%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="TB regimen" value="New TB drugs" />
          <comment>
            <narrative>Numerator: 3486; Denominator: 3635; Percentage: 95.9%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="TB regimen" value="New TB drugs" />
          <comment>
            <narrative>Numerator: 3486; Denominator: 3635; Percentage: 95.9%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="TB regimen" value="New TB drugs" />
          <comment>
            <narrative>Numerator: 3486; Denominator: 3635; Percentage: 95.9%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 2235; Denominator: 3635; Percentage: 61.49%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 2235; Denominator: 3635; Percentage: 61.49%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 2235; Denominator: 3635; Percentage: 61.49%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 2235; Denominator: 3635; Percentage: 61.49%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 2235; Denominator: 3635; Percentage: 61.49%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 2235; Denominator: 3635; Percentage: 61.49%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2022-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 2101.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1798.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1748; Denominator: 1798; Percentage: 97.22%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 50; Denominator: 1799; Percentage: 2.78%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 752; Denominator: 1798; Percentage: 41.82%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1046; Denominator: 1798; Percentage: 58.18%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 1193; Denominator: 1799; Percentage: 66.31%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2023-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 4203.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3230.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-10-01" />
          <period-end iso-date="2023-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 2102.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1432.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1388.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 44.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 587.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 845.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="New TB drugs" />
            <comment>
              <narrative>Numerator: 1296.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 811.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2023-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 2160.9.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1423.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1378.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 43.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 578.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 843.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 803.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2024-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 4321.8.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3281.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-10-01" />
          <period-end iso-date="2024-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 2160.9.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1858.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1778; Denominator: 1858; Percentage: 95.69%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 80; Denominator: 1858; Percentage: 4.31%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 727; Denominator: 1858; Percentage: 39.13%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1131; Denominator: 1858; Percentage: 60.87%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 1366; Denominator: 1858; Percentage: 73.52%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 4164.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3662.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 2082.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 2082.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1740.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1650.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 90.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 676.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1064.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="New TB drugs" />
            <comment>
              <narrative>Numerator: 1355.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 1462.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 2032.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1721.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1646.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 75.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 687.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1034.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="New TB drugs" />
            <comment>
              <narrative>Numerator: 1416.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 1478.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate of RR TB and/or MDR-TB: Percentage of cases with RR and/or MDR-TB successfully treated</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Treatment success rate of RR TB and/or MDR-TB: Percentage of cases with RR and/or MDR-TB successfully treated</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 2059; Denominator: 3093; Percentage: 66.57%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1947; Denominator: 3093; Percentage: 62.95%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1947; Denominator: 3093; Percentage: 62.95%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1947; Denominator: 3093; Percentage: 62.95%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1947; Denominator: 3093; Percentage: 62.95%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 112; Denominator: 3093; Percentage: 3.62%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 112; Denominator: 3093; Percentage: 3.62%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 112; Denominator: 3093; Percentage: 3.62%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 112; Denominator: 3093; Percentage: 3.62%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 865; Denominator: 3093; Percentage: 27.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 865; Denominator: 3093; Percentage: 27.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 865; Denominator: 3093; Percentage: 27.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 865; Denominator: 3093; Percentage: 27.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1194; Denominator: 3093; Percentage: 38.6%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1194; Denominator: 3093; Percentage: 38.6%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1194; Denominator: 3093; Percentage: 38.6%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1194; Denominator: 3093; Percentage: 38.6%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 1340; Denominator: 3093; Percentage: 43.32%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 1340; Denominator: 3093; Percentage: 43.32%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 1340; Denominator: 3093; Percentage: 43.32%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 1340; Denominator: 3093; Percentage: 43.32%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Type of TB" value="XDR TB" />
          <comment>
            <narrative>Numerator: 142; Denominator: 237; Percentage: 59.92%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Type of TB" value="XDR TB" />
          <comment>
            <narrative>Numerator: 142; Denominator: 237; Percentage: 59.92%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Type of TB" value="XDR TB" />
          <comment>
            <narrative>Numerator: 142; Denominator: 237; Percentage: 59.92%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Type of TB" value="XDR TB" />
          <comment>
            <narrative>Numerator: 142; Denominator: 237; Percentage: 59.92%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2023-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 1535; Denominator: 2235; Percentage: 68.7%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1065; Denominator: 1595; Percentage: 66.8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-10-01" />
          <period-end iso-date="2023-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 1535; Denominator: 2235; Percentage: 69%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1065; Denominator: 1595; Percentage: 66.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1035.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 30.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 440.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 625.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 729.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2024-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 1743; Denominator: 2461; Percentage: 70.8%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1019; Denominator: 1546; Percentage: 65.9%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-10-01" />
          <period-end iso-date="2024-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 1743; Denominator: 2461; Percentage: 71%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1019; Denominator: 1546; Percentage: 65.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 980; Denominator: 1019; Percentage: 96.17%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 39; Denominator: 1019; Percentage: 3.83%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 431; Denominator: 1019; Percentage: 42.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 588; Denominator: 1019; Percentage: 57.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 691; Denominator: 1019; Percentage: 67.81%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 1796; Denominator: 2566; Percentage: 70%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1751; Denominator: 2517; Percentage: 69.57%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 1796; Denominator: 2566; Percentage: 69.99%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1751; Denominator: 2517; Percentage: 69.57%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1637; Denominator: 1751; Percentage: 93.49%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 114; Denominator: 1751; Percentage: 6.51%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 712; Denominator: 1751; Percentage: 40.66%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1039; Denominator: 1751; Percentage: 59.34%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 1031; Denominator: 1751; Percentage: 58.88%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="XDR TB" />
            <comment>
              <narrative>Numerator: 0; Denominator: 1751; Percentage: 0%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 1384; Denominator: 1922; Percentage: 72.01%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1235; Denominator: 1568; Percentage: 78.76%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1174; Denominator: 1235; Percentage: 95.06%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 61; Denominator: 1235; Percentage: 4.94%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 492; Denominator: 1235; Percentage: 39.84%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 743; Denominator: 1235; Percentage: 60.16%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 720; Denominator: 1235; Percentage: 58.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="XDR TB" />
            <comment>
              <narrative>Numerator: 0; Denominator: 1235; Percentage: 0%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Completeness of facility reporting: Percentage of expected facility monthly reports (for the reporting period) that are actually received</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Health management information systems and M&amp;E.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Completeness of facility reporting: Percentage of expected facility monthly reports (for the reporting period) that are actually received</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2021" iso-date="2021-12-31">
          <comment>
            <narrative>Numerator: 4724; Denominator: 4765; Percentage: 99.14%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Report type" value="HIV reports" />
          <comment>
            <narrative>Numerator: 4115; Denominator: 4135; Percentage: 99.52%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Report type" value="HIV reports" />
          <comment>
            <narrative>Numerator: 4115; Denominator: 4135; Percentage: 99.52%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Report type" value="HIV reports" />
          <comment>
            <narrative>Numerator: 4115; Denominator: 4135; Percentage: 99.52%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Report type" value="HIV reports" />
          <comment>
            <narrative>Numerator: 4115; Denominator: 4135; Percentage: 99.52%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Report type" value="HIV reports" />
          <comment>
            <narrative>Numerator: 4115; Denominator: 4135; Percentage: 99.52%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Report type" value="HIV reports" />
          <comment>
            <narrative>Numerator: 4115; Denominator: 4135; Percentage: 99.52%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Report type" value="TB reports" />
          <comment>
            <narrative>Numerator: 4724; Denominator: 4765; Percentage: 99.14%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Report type" value="TB reports" />
          <comment>
            <narrative>Numerator: 4724; Denominator: 4765; Percentage: 99.14%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Report type" value="TB reports" />
          <comment>
            <narrative>Numerator: 4724; Denominator: 4765; Percentage: 99.14%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Report type" value="TB reports" />
          <comment>
            <narrative>Numerator: 4724; Denominator: 4765; Percentage: 99.14%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Report type" value="TB reports" />
          <comment>
            <narrative>Numerator: 4724; Denominator: 4765; Percentage: 99.14%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Report type" value="TB reports" />
          <comment>
            <narrative>Numerator: 4724; Denominator: 4765; Percentage: 99.14%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2022-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 4724; Denominator: 4765; Percentage: 99%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4789; Denominator: 4827; Percentage: 99.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Report type" value="HIV reports" />
            <comment>
              <narrative>Numerator: 4842; Denominator: 4873; Percentage: 99.36%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Report type" value="TB reports" />
            <comment>
              <narrative>Numerator: 4789; Denominator: 4827; Percentage: 99.21%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2023-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 9448; Denominator: 9530; Percentage: 99.1%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 9584; Denominator: 9677; Percentage: 99%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-10-01" />
          <period-end iso-date="2023-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 4724; Denominator: 4765; Percentage: 99%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4795; Denominator: 4850; Percentage: 98.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Report type" value="HIV reports" />
            <comment>
              <narrative>Numerator: 4854.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Report type" value="TB reports" />
            <comment>
              <narrative>Numerator: 4785.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2024-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 9448; Denominator: 9530; Percentage: 99.1%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 9802; Denominator: 9915; Percentage: 98.9%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2023-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 4724; Denominator: 4765; Percentage: 99%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4865; Denominator: 4944; Percentage: 98.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Report type" value="HIV reports" />
            <comment>
              <narrative>Numerator: 4069.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Report type" value="TB reports" />
            <comment>
              <narrative>Numerator: 4865.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-10-01" />
          <period-end iso-date="2024-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 4724; Denominator: 4765; Percentage: 99%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4937; Denominator: 4971; Percentage: 99.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Report type" value="HIV reports" />
            <comment>
              <narrative>Numerator: 4113; Denominator: 4122; Percentage: 99.78%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Report type" value="TB reports" />
            <comment>
              <narrative>Numerator: 4937; Denominator: 4971; Percentage: 99.32%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 9448; Denominator: 9530; Percentage: 99.1%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 9891; Denominator: 9956; Percentage: 99.35%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 4724; Denominator: 4765; Percentage: 99.14%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 4724; Denominator: 4765; Percentage: 99.14%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4938; Denominator: 4967; Percentage: 99.42%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Report type" value="HIV reports" />
            <comment>
              <narrative>Numerator: 4892; Denominator: 4923; Percentage: 99.37%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Report type" value="TB reports" />
            <comment>
              <narrative>Numerator: 4938; Denominator: 4967; Percentage: 99.42%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 4869; Denominator: 4901; Percentage: 99.35%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4903; Denominator: 4958; Percentage: 98.89%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Report type" value="HIV reports" />
            <comment>
              <narrative>Numerator: 4862; Denominator: 4904; Percentage: 99.14%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Report type" value="TB reports" />
            <comment>
              <narrative>Numerator: 4903; Denominator: 4956; Percentage: 98.93%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>HR-Other 1: Number of health care providers trained on medical ethics and Human rights</narrative>
      </title>
      <description>
        <narrative>Module: Reducing human rights-related barriers to HIV/TB services.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>HR-Other 1: Number of health care providers trained on medical ethics and Human rights</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2021" iso-date="2021-12-31">
          <comment>
            <narrative>Numerator: 5472.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2023-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 3250.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2022-10-01" />
          <period-end iso-date="2023-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 3250.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2024-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 8126.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 586.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2023-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 4063.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-10-01" />
          <period-end iso-date="2024-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 4063.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 586.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 4063.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 8126.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 9434; Denominator: 8126; Percentage: 116.1%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 4063.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4084; Denominator: 8126; Percentage: 50.26%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31">
          <comment>
            <narrative>Numerator: 80795.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 39464; Denominator: 80795; Percentage: 48.84%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 39464; Denominator: 80795; Percentage: 48.84%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 39464; Denominator: 80795; Percentage: 48.84%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 39464; Denominator: 80795; Percentage: 48.84%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 39464; Denominator: 80795; Percentage: 48.84%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 39464; Denominator: 80795; Percentage: 48.84%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2022-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 55860.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 43137.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 21593; Denominator: 43137; Percentage: 50.06%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2023-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 111720.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 76772.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-10-01" />
          <period-end iso-date="2023-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 55860.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 33635.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 18644.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2023-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 57443.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 33439.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 18241.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2024-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 114887.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 80707.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-10-01" />
          <period-end iso-date="2024-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 57444.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 47268.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 24133; Denominator: 47268; Percentage: 51.06%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 106112.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 101166.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 53056.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 53056.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 52144.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 24698.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 49887.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 49487.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 23418.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="7044" />
        <baseline year="2020" iso-date="2020-12-31" value="7044">
          <dimension name="Age" value="&lt;5" />
        </baseline>
        <baseline year="2020" iso-date="2020-12-31" value="7044">
          <dimension name="Age" value="&lt;5" />
        </baseline>
        <baseline year="2020" iso-date="2020-12-31" value="7044">
          <dimension name="Age" value="&lt;5" />
        </baseline>
        <baseline year="2020" iso-date="2020-12-31" value="7044">
          <dimension name="Age" value="&lt;5" />
        </baseline>
        <baseline year="2020" iso-date="2020-12-31" value="7044">
          <dimension name="Age" value="&lt;5" />
        </baseline>
        <baseline year="2020" iso-date="2020-12-31" value="7044">
          <dimension name="Age" value="&lt;5" />
        </baseline>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2023-03-31" />
          <target value="7748" />
          <actual value="5711" />
        </period>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2022-09-30" />
          <target value="3874" />
          <actual value="4255" />
          <actual value="4255">
            <dimension name="Age" value="&lt;5" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-10-01" />
          <period-end iso-date="2023-03-31" />
          <target value="3874" />
          <actual value="1456" />
          <actual value="1456">
            <dimension name="Age" value="&lt;5" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2023-09-30" />
          <target value="4226" />
          <actual value="2479" />
          <actual value="2479">
            <dimension name="Age" value="&lt;5" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2024-03-31" />
          <target value="8453" />
          <actual value="5829" />
        </period>
        <period>
          <period-start iso-date="2023-10-01" />
          <period-end iso-date="2024-03-31" />
          <target value="4227" />
          <actual value="3350" />
          <actual value="3350">
            <dimension name="Age" value="&lt;5" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target value="9157" />
          <actual value="9946" />
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target value="4578" />
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target value="4579" />
          <actual value="5205" />
          <actual value="5205">
            <dimension name="Age" value="&lt;5" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target value="24875" />
          <actual value="22471" />
          <actual value="4650">
            <dimension name="Age" value="&lt;5" />
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="84.41">
          <comment>
            <narrative>Numerator: 68199; Denominator: 80795.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2023-03-31" />
          <target value="87" />
          <actual value="81">
            <comment>
              <narrative>Numerator: 50789; Denominator: 62727.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2022-09-30" />
          <target value="87" />
          <actual value="80.2">
            <comment>
              <narrative>Numerator: 27657; Denominator: 34482.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-10-01" />
          <period-end iso-date="2023-03-31" />
          <target value="87" />
          <actual value="81.9">
            <comment>
              <narrative>Numerator: 23132; Denominator: 28245.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2023-09-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 50274; Denominator: 55860.</narrative>
            </comment>
          </target>
          <actual value="82.2">
            <comment>
              <narrative>Numerator: 25164; Denominator: 30607.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2024-03-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 100548; Denominator: 111720.</narrative>
            </comment>
          </target>
          <actual value="76.6">
            <comment>
              <narrative>Numerator: 57260; Denominator: 74725.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-10-01" />
          <period-end iso-date="2024-03-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 50274; Denominator: 55860.</narrative>
            </comment>
          </target>
          <actual value="72.8">
            <comment>
              <narrative>Numerator: 32096; Denominator: 44118.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target value="83">
            <comment>
              <narrative>Numerator: 78048; Denominator: 94033.</narrative>
            </comment>
          </target>
          <actual value="76.38">
            <comment>
              <narrative>Numerator: 76912; Denominator: 100691.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target value="83">
            <comment>
              <narrative>Numerator: 42375; Denominator: 51054.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target value="83">
            <comment>
              <narrative>Numerator: 35673; Denominator: 42979.</narrative>
            </comment>
          </target>
          <actual value="76.74">
            <comment>
              <narrative>Numerator: 40907; Denominator: 53307.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target value="86">
            <comment>
              <narrative>Numerator: 42387; Denominator: 49287.</narrative>
            </comment>
          </target>
          <actual value="76.67">
            <comment>
              <narrative>Numerator: 38196; Denominator: 49817.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="87.16">
          <comment>
            <narrative>Numerator: 34395; Denominator: 39464.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2023-03-31" />
          <target value="89.6">
            <comment>
              <narrative>Numerator: 48793; Denominator: 54479.</narrative>
            </comment>
          </target>
          <actual value="89.3">
            <comment>
              <narrative>Numerator: 35944; Denominator: 40237.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2022-09-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 24396; Denominator: 27239.</narrative>
            </comment>
          </target>
          <actual value="88">
            <comment>
              <narrative>Numerator: 19003; Denominator: 21593.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-10-01" />
          <period-end iso-date="2023-03-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 24397; Denominator: 27240.</narrative>
            </comment>
          </target>
          <actual value="90.9">
            <comment>
              <narrative>Numerator: 16941; Denominator: 18644.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2024-03-31" />
          <target value="90.6">
            <comment>
              <narrative>Numerator: 50613; Denominator: 55843.</narrative>
            </comment>
          </target>
          <actual value="92">
            <comment>
              <narrative>Numerator: 38979; Denominator: 42372.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2023-09-30" />
          <target value="91">
            <comment>
              <narrative>Numerator: 25306; Denominator: 27921.</narrative>
            </comment>
          </target>
          <actual value="91.3">
            <comment>
              <narrative>Numerator: 16655; Denominator: 18241.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-10-01" />
          <period-end iso-date="2024-03-31" />
          <target value="91">
            <comment>
              <narrative>Numerator: 25307; Denominator: 27922.</narrative>
            </comment>
          </target>
          <actual value="92.5">
            <comment>
              <narrative>Numerator: 22324; Denominator: 24131.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target value="92">
            <comment>
              <narrative>Numerator: 47834; Denominator: 51994.</narrative>
            </comment>
          </target>
          <actual value="94.24">
            <comment>
              <narrative>Numerator: 45427; Denominator: 48201.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target value="92">
            <comment>
              <narrative>Numerator: 23917; Denominator: 25997.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target value="92">
            <comment>
              <narrative>Numerator: 23917; Denominator: 25997.</narrative>
            </comment>
          </target>
          <actual value="94.57">
            <comment>
              <narrative>Numerator: 23358; Denominator: 24698.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target value="95.31">
            <comment>
              <narrative>Numerator: 23074; Denominator: 24209.</narrative>
            </comment>
          </target>
          <actual value="94.85">
            <comment>
              <narrative>Numerator: 22213; Denominator: 23418.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of PLHIV on ART who initiated TB preventive therapy among those eligible during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of PLHIV on ART who initiated TB preventive therapy among those eligible during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="92.22">
          <comment>
            <narrative>Numerator: 188967; Denominator: 204903.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2023-03-31" />
          <target value="93">
            <comment>
              <narrative>Numerator: 192466; Denominator: 206952.</narrative>
            </comment>
          </target>
          <actual value="87.8">
            <comment>
              <narrative>Numerator: 110744; Denominator: 126176.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2022-09-30" />
          <target value="93">
            <comment>
              <narrative>Numerator: 96233; Denominator: 103476.</narrative>
            </comment>
          </target>
          <actual value="87.1">
            <comment>
              <narrative>Numerator: 59344; Denominator: 68153.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-10-01" />
          <period-end iso-date="2023-03-31" />
          <target value="93">
            <comment>
              <narrative>Numerator: 96233; Denominator: 103476.</narrative>
            </comment>
          </target>
          <actual value="88.6">
            <comment>
              <narrative>Numerator: 51400; Denominator: 58023.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2023-09-30" />
          <target value="94">
            <comment>
              <narrative>Numerator: 98240; Denominator: 104511.</narrative>
            </comment>
          </target>
          <actual value="93">
            <comment>
              <narrative>Numerator: 31055; Denominator: 33399.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2024-03-31" />
          <target value="94">
            <comment>
              <narrative>Numerator: 196480; Denominator: 209022.</narrative>
            </comment>
          </target>
          <actual value="92.8">
            <comment>
              <narrative>Numerator: 89385; Denominator: 96371.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-10-01" />
          <period-end iso-date="2024-03-31" />
          <target value="94">
            <comment>
              <narrative>Numerator: 98240; Denominator: 104511.</narrative>
            </comment>
          </target>
          <actual value="92.6">
            <comment>
              <narrative>Numerator: 58330; Denominator: 62972.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 200556; Denominator: 211112.</narrative>
            </comment>
          </target>
          <actual value="95.25">
            <comment>
              <narrative>Numerator: 123656; Denominator: 129822.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target value="95">
            <comment>
              <narrative>Numerator: 100278; Denominator: 105556.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 100278; Denominator: 105556.</narrative>
            </comment>
          </target>
          <actual value="90.3">
            <comment>
              <narrative>Numerator: 54890; Denominator: 60789.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target value="95.24">
            <comment>
              <narrative>Numerator: 74600; Denominator: 78330.</narrative>
            </comment>
          </target>
          <actual value="78.02">
            <comment>
              <narrative>Numerator: 44088; Denominator: 56511.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31">
          <comment>
            <narrative>Numerator: 5117541; Denominator: 8008080; Percentage: 63.9%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 4906094; Denominator: 7892070; Percentage: 62.16%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 4906094; Denominator: 7892070; Percentage: 62.16%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 4906094; Denominator: 7892070; Percentage: 62.16%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 4906094; Denominator: 7892070; Percentage: 62.16%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 139828; Denominator: 7892070; Percentage: 1.77%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 139828; Denominator: 7892070; Percentage: 1.77%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 139828; Denominator: 7892070; Percentage: 1.77%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 139828; Denominator: 7892070; Percentage: 1.77%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Duration of treatment" value="Newly initiating ART" />
          <comment>
            <narrative>Numerator: 541465; Denominator: 7892070; Percentage: 6.86%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Duration of treatment" value="Newly initiating ART" />
          <comment>
            <narrative>Numerator: 541465; Denominator: 7892070; Percentage: 6.86%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Duration of treatment" value="Newly initiating ART" />
          <comment>
            <narrative>Numerator: 541465; Denominator: 7892070; Percentage: 6.86%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Duration of treatment" value="Newly initiating ART" />
          <comment>
            <narrative>Numerator: 541465; Denominator: 7892070; Percentage: 6.86%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2023-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 5707564; Denominator: 8110600; Percentage: 70%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5437913; Denominator: 8110600; Percentage: 67%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-10-01" />
          <period-end iso-date="2023-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 5707564; Denominator: 8110600; Percentage: 70%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5437913; Denominator: 8110600; Percentage: 67%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 5326130.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 111783.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Duration of treatment" value="Newly initiating ART" />
            <comment>
              <narrative>Numerator: 211012.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2024-03-31" />
          <actual>
            <comment>
              <narrative>Numerator: 5549084; Denominator: 7809260; Percentage: 71.1%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-10-01" />
          <period-end iso-date="2024-03-31" />
          <actual>
            <comment>
              <narrative>Numerator: 5549084; Denominator: 7809260; Percentage: 71.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 5446406; Denominator: 7809260; Percentage: 69.74%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 102678; Denominator: 7809260; Percentage: 1.31%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Duration of treatment" value="Newly initiating ART" />
            <comment>
              <narrative>Numerator: 192331; Denominator: 7809260; Percentage: 2.46%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 6037450; Denominator: 7881970; Percentage: 76.6%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 6542035; Denominator: 7881970; Percentage: 83%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5614691; Denominator: 7881970; Percentage: 71.23%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 6542035; Denominator: 7881970; Percentage: 83%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5614691; Denominator: 7881970; Percentage: 71.23%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 5521843; Denominator: 7881970; Percentage: 70.06%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 92848; Denominator: 7881970; Percentage: 1.18%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Duration of treatment" value="Newly initiating ART" />
            <comment>
              <narrative>Numerator: 214173; Denominator: 7881970; Percentage: 2.72%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 6594815; Denominator: 7945560; Percentage: 83%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 6391130; Denominator: 8124260; Percentage: 78.67%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 6297620; Denominator: 7980580; Percentage: 78.91%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 93508; Denominator: 143680; Percentage: 65.08%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Duration of treatment" value="Newly initiating ART" />
            <comment>
              <narrative>Numerator: 214473; Denominator: 8124260; Percentage: 2.64%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-10T13:42:47+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-ZAF-C-NDOH-4</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Investing for impact against Tuberculosis and HIV - South Africa (01-Oct-2025-31-Mar-2028)</narrative>
    </title>
    <description type="1">
      <narrative>South Africa, TB/HIV, National Department of Health of the Republic of South Africa</narrative>
    </description>
    <description type="2">
      <narrative>Goals: Break down barriers to achieving solutions for HIV, TB and STIs; Maximise equitable and equal access to services and solutions for HIV, TB and STIs; Build resilient systems for HIV, TB and STIs that are integrated into systems for health, social protection, and pandemic response. Objectives: Strengthen TB diagnosis and support for PWTB and accelerate scale up of innovative processes, diagnostic tools and regimens for the diagnosis, treatment and care for PWTB; Strengthen TB-prevention interventions for key and other priority populations and implement airborne infection-prevention and control in health facilities and high-risk indoor places; Ensure that 95% of PLHIV, especially key and other priority populations, know their status and 95% of them are on treatment, and 95% of those on treatment are retained in care and achieve long-term viral suppression; Harness technology and innovation to fight the epidemics with the latest available tools; Build a stronger public health supply chain management and support the acceleration of the approval of new health products.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="10" role="2" crs-channel-code="12001">
      <narrative>National Department of Health of the Republic of South Africa</narrative>
    </participating-org>
    <participating-org type="10" role="4" crs-channel-code="12001">
      <narrative>National Department of Health of the Republic of South Africa</narrative>
    </participating-org>
    <other-identifier ref="ZAF-C-NDOHP04" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="2" />
    <activity-date type="1" iso-date="2025-10-01" />
    <activity-date type="2" iso-date="2025-10-01" />
    <activity-date type="3" iso-date="2028-03-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>John Ochero</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>john.ochero@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="ZA" percentage="100">
      <narrative>South Africa</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="46.05">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="27.69">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <sector vocabulary="1" code="13040" percentage="26.26">
      <narrative>HIV</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="ae365c24-71a9-48d4-b3ee-c436f513a41a" percentage="0.02">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Self-testing for AGYW and their male sexual partners programs</narrative>
        </description>
      </budget-item>
      <budget-item code="48867067-7709-4cef-94a9-7dcc66211686" percentage="0.01">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Self-testing for KP programs</narrative>
        </description>
      </budget-item>
      <budget-item code="c7596dbc-702f-4654-8ff9-9bea34d5790c" percentage="0.03">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Self-testing outside of KP and AGYW programs</narrative>
        </description>
      </budget-item>
      <budget-item code="54f285ef-8db0-40b2-8052-f00a00522b8d" percentage="0.01">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Integrated testing of pregnant women for HIV, syphilis and hepatitis B</narrative>
        </description>
      </budget-item>
      <budget-item code="3eb32c17-6380-4aa6-8a3b-73b4cb922dee" percentage="0.07">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Post-natal infant prophylaxis</narrative>
        </description>
      </budget-item>
      <budget-item code="698ea3f4-346f-4df8-ab2e-c01a47bbccd9" percentage="0.22">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Prevention of incident HIV among pregnant and breastfeeding women</narrative>
        </description>
      </budget-item>
      <budget-item code="1ef60004-7321-4f53-93cf-6bdfa56924ef" percentage="0.29">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Retention support for pregnant and breastfeeding women (facility and community)</narrative>
        </description>
      </budget-item>
      <budget-item code="9d329dd4-6e6b-430c-80f6-afb56fbbbacd" percentage="0.21">
        <description>
          <narrative>HIV -&gt; Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -&gt; Condom and lubricant programming for AGYW in high HIV incidence settings</narrative>
        </description>
      </budget-item>
      <budget-item code="1240f978-9714-4e2a-9e31-d18773f6e595" percentage="10.98">
        <description>
          <narrative>HIV -&gt; Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -&gt; Pre-exposure prophylaxis (PrEP) programming for AGYW in high HIV incidence settings</narrative>
        </description>
      </budget-item>
      <budget-item code="47ac0494-6213-481b-a81d-d00d7dca8f99" percentage="0.25">
        <description>
          <narrative>HIV -&gt; Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -&gt; Pre-exposure prophylaxis (PrEP) programming for male sexual partners of AGYW in high HIV incidence settings</narrative>
        </description>
      </budget-item>
      <budget-item code="7a803e07-8560-47f6-9b59-72193d6812db" percentage="0.55">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Condom and lubricant programming for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="7300b0bf-fc7f-49ac-b933-534346c226a5" percentage="0.5">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="1d7ecc3b-d5b9-48ca-a9e7-d8fa38cf3455" percentage="0.01">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Condom and lubricant programming for PUD</narrative>
        </description>
      </budget-item>
      <budget-item code="e2889950-b814-4736-95c3-6957c4461ebe" percentage="0.12">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for PUD</narrative>
        </description>
      </budget-item>
      <budget-item code="94dbd87e-0cec-46fb-83f5-7c805de185cb" percentage="0.18">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Condom and lubricant programming for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="4ad468bf-4376-466e-944a-b25f3e1b00ee" percentage="0.37">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="daac344e-ec8e-4193-9c8a-266fdd2e69ac" percentage="0.27">
        <description>
          <narrative>HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; Condom and lubricant programming for transgender people</narrative>
        </description>
      </budget-item>
      <budget-item code="6853dd18-909c-4836-8981-2e434afc456c" percentage="0.25">
        <description>
          <narrative>HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for transgender people</narrative>
        </description>
      </budget-item>
      <budget-item code="a4e4d0e7-9dfd-49d8-8030-0f9cc9b713fc" percentage="0.17">
        <description>
          <narrative>HIV -&gt; Prevention program stewardship -&gt; Prevention program stewardship</narrative>
        </description>
      </budget-item>
      <budget-item code="39d71dad-c8af-467d-9fcc-8ac534b86784" percentage="1.66">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Ensuring nondiscriminatory provision of health care</narrative>
        </description>
      </budget-item>
      <budget-item code="d49b353e-9087-48e0-9c3b-f8ed91d6fd53" percentage="9.77">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - adults (15 and above)</narrative>
        </description>
      </budget-item>
      <budget-item code="6bb2376e-8c74-4cf1-98f0-f72ea58797fa" percentage="0.03">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - children (under 15)</narrative>
        </description>
      </budget-item>
      <budget-item code="75665eb3-7cb7-4083-b197-c97fcbe30044" percentage="0.28">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Viral load and antiretroviral (ARV) toxicity</narrative>
        </description>
      </budget-item>
      <budget-item code="cd09d6c8-13e6-412e-a54d-84c32d99a370" percentage="1.33">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="43337786-bfab-487f-b388-9fbe8808948d" percentage="7.73">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="57ef74d8-840a-4792-b7d8-0c12163d7d91" percentage="0.58">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Biosafety and biosecurity, infrastructure and equipment</narrative>
        </description>
      </budget-item>
      <budget-item code="376b4c32-f875-4663-ba6e-759f6042be74" percentage="0">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Laboratory supply chain systems</narrative>
        </description>
      </budget-item>
      <budget-item code="0aa54232-09ea-488b-86df-48a82af99ed4" percentage="0.55">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Quality management systems and accreditation</narrative>
        </description>
      </budget-item>
      <budget-item code="a964bfef-7776-4f8c-bf11-c2f904336a18" percentage="0.14">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Specimen referral and transport system</narrative>
        </description>
      </budget-item>
      <budget-item code="9489918c-160e-4868-89f0-24a1320c8e8d" percentage="1.3">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Medical oxygen and respiratory care system -&gt; RSSH/PP: Bulk Oxygen supply</narrative>
        </description>
      </budget-item>
      <budget-item code="7dbf6454-4357-4937-89a1-9a1c7f0174fa" percentage="0.2">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community engagement, linkages and coordination</narrative>
        </description>
      </budget-item>
      <budget-item code="20ec7d90-e6c6-4769-a81d-e6b1e7987227" percentage="0.02">
        <description>
          <narrative>RSSH -&gt; RSSH: Health financing systems -&gt; Blended financing arrangements</narrative>
        </description>
      </budget-item>
      <budget-item code="e7ae970e-44ac-44a1-b3e1-cbff96079a5d" percentage="0.03">
        <description>
          <narrative>RSSH -&gt; RSSH: Health financing systems -&gt; Health financing data and analytics</narrative>
        </description>
      </budget-item>
      <budget-item code="4f5c256c-b6d1-40ea-9bd7-f061f042bc98" percentage="0.14">
        <description>
          <narrative>RSSH -&gt; RSSH: Health financing systems -&gt; Health financing strategies and planning</narrative>
        </description>
      </budget-item>
      <budget-item code="9047155e-4a95-4897-b0bd-857d3f703670" percentage="0.17">
        <description>
          <narrative>RSSH -&gt; RSSH: Health financing systems -&gt; Routine financial management systems</narrative>
        </description>
      </budget-item>
      <budget-item code="49227074-d9ed-412b-b8b5-0fadf80db456" percentage="5.11">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Augmenting national supply chain system with outsourcing</narrative>
        </description>
      </budget-item>
      <budget-item code="48d7f7e3-61fc-4c8d-88f3-aefc44da79dc" percentage="0.69">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Planning and procurement capacity</narrative>
        </description>
      </budget-item>
      <budget-item code="78165abf-6e6d-46ad-b445-d380c1037123" percentage="0.27">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Policy, strategy, governance</narrative>
        </description>
      </budget-item>
      <budget-item code="1e7328c2-4fcd-47b0-8e3c-31a8a421d74c" percentage="3.13">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Regulatory/quality assurance support</narrative>
        </description>
      </budget-item>
      <budget-item code="31d3a0e8-e9f1-4c88-b1b7-ce75b4e952eb" percentage="0.63">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Storage and distribution capacity, design &amp; operations</narrative>
        </description>
      </budget-item>
      <budget-item code="0e90e07b-37cc-4294-9a44-c1afd707a824" percentage="0.21">
        <description>
          <narrative>RSSH -&gt; RSSH: Health sector planning and governance for integrated people-centered services -&gt; Integration/coordination across disease programs and at the service delivery level</narrative>
        </description>
      </budget-item>
      <budget-item code="2c341d5c-b46c-47a9-9aff-2700be47f75e" percentage="0.03">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Analyses, evaluations, reviews and data use</narrative>
        </description>
      </budget-item>
      <budget-item code="f94cd008-2af3-49cf-9149-7be7cf0228e7" percentage="0.18">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="42e7a4b3-fa75-4c16-8a4d-110492b156f4" percentage="5.25">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="1da38701-f878-40c8-aeaf-621a89991324" percentage="0.01">
        <description>
          <narrative>Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Private provider engagement in TB/DR-TB care</narrative>
        </description>
      </budget-item>
      <budget-item code="ea39b4f6-cd94-4310-b181-394f794f9144" percentage="21.4">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB diagnosis/drug susceptibility testing (DST)</narrative>
        </description>
      </budget-item>
      <budget-item code="5b20da70-c625-405c-858b-6de52626ae46" percentage="0.1">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="f50f08b4-b9d9-4b4a-a8b2-065858f9ce31" percentage="14.93">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB screening and diagnosis</narrative>
        </description>
      </budget-item>
      <budget-item code="003bd5ec-d813-43cd-9bae-ec060870a2c4" percentage="8.51">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="7332ed72-b538-4ab5-b90e-f820e56c0c5b" percentage="0.72">
        <description>
          <narrative>Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Infection prevention and control (IPC)</narrative>
        </description>
      </budget-item>
      <budget-item code="68262ac7-05ab-4aec-9c9e-320d5883c55c" percentage="0.31">
        <description>
          <narrative>Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Screening/testing for TB infection</narrative>
        </description>
      </budget-item>
      <budget-item code="7c7a7505-bdfe-4146-976c-78a03ca0d545" percentage="0.08">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Screening, testing and diagnosis</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">38371894.06</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2026-01-01" />
      <period-end iso-date="2026-12-31" />
      <value currency="USD" value-date="2026-01-01">109803880.66</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2027-01-01" />
      <period-end iso-date="2027-12-31" />
      <value currency="USD" value-date="2027-01-01">86337171.44</value>
    </budget>
    <capital-spend percentage="7.2" />
    <transaction ref="57430412-3564-491e-a793-e112b9db4ca4">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-10-23" />
      <value currency="USD" value-date="2025-10-23">10849800.00</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="80947b61-143c-44c5-8704-269d7d4f13ac">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-10-25" />
      <value currency="USD" value-date="2025-10-25">-10849800.00</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9d0645a0-b876-4164-8cc8-6c022dba3494">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-10-25" />
      <value currency="USD" value-date="2025-10-25">10278000.00</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b804a27f-1f48-4be4-834e-fc75c9a859c0">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-02-26" />
      <value currency="USD" value-date="2026-02-26">81285834.44</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="da24a7b7-33c0-45cb-8135-f660818fdb3a">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-03-03" />
      <value currency="USD" value-date="2026-03-03">14258849.39</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP04 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e71c678b-cddc-4be8-91e0-6845b1f6a5dc">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-15" />
      <value currency="USD" value-date="2026-04-15">1137600.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="03a5591a-1804-4042-8b3d-6d9e8fba5e37">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-15" />
      <value currency="USD" value-date="2026-04-15">241450.00</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c17171d3-bc76-47ce-ae28-9af2f289a4f9">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-05-19" />
      <value currency="USD" value-date="2026-05-19">18302214.30</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP04 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="abae0b57-fb0f-4e00-b880-500d146293ee">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-01" />
      <value currency="USD" value-date="2026-07-01">594000.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="0830e83d-498c-49ec-8548-a500e4e284a7">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-07" />
      <value currency="USD" value-date="2026-07-07">432000.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="3e85a82d-3b23-405b-8613-80aa72b9a65c">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-07" />
      <value currency="USD" value-date="2026-07-07">432000.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="7980de3d-1cda-4e1c-ba31-964601d7766c">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-07" />
      <value currency="USD" value-date="2026-07-07">432000.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="c4c28fa0-3a98-44f7-9ad1-7db874ffe4ca">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-07" />
      <value currency="USD" value-date="2026-07-07">432000.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="0d213793-7106-435c-a5de-b2b752a74338">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-08-11" />
      <value currency="USD" value-date="2026-08-11">20380889.26</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP04 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1c4ee487-0e2c-475d-b39e-d29b56b0a433">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-09-01" />
      <value currency="USD" value-date="2026-09-01">164450.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="30914c02-f9ac-4f8d-8f76-12af1dc1de46">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-09-29" />
      <value currency="USD" value-date="2026-09-29">15416249.81</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP04 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/ZAF-C-NDOH" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-10" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/ZAF/2024/HIV_TB/en/ZAF-C_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2024 - Funding Request - Window 6 - South Africa - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1691-ZAF-C.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2024-09-09" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2024" iso-date="2024-12-31">
          <comment>
            <narrative>Numerator: 4201.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3989; Denominator: 4201; Percentage: 94.95%.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 114; Denominator: 4201; Percentage: 2.71%.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1602; Denominator: 4201; Percentage: 38.13%.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 2502; Denominator: 4201; Percentage: 59.56%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 2852.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-04-01" />
          <period-end iso-date="2026-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 2407.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 2714.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-04-01" />
          <period-end iso-date="2027-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 2276.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-10-01" />
          <period-end iso-date="2028-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 2566.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2024" iso-date="2024-12-31">
          <comment>
            <narrative>Numerator: 3692; Denominator: 4201; Percentage: 87.88%.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3507; Denominator: 3692; Percentage: 94.99%.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 184; Denominator: 3692; Percentage: 4.98%.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1475; Denominator: 3692; Percentage: 39.95%.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31">
          <dimension name="Treatment regimen" value="Longer individualized" />
          <comment>
            <narrative>Numerator: 632; Denominator: 3692; Percentage: 17.12%.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 2217; Denominator: 3692; Percentage: 60.05%.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31">
          <dimension name="Treatment regimen" value="Shorter 6-9 month" />
          <comment>
            <narrative>Numerator: 2681; Denominator: 3692; Percentage: 72.62%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 2510; Denominator: 2852; Percentage: 88.01%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Longer individualized" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Shorter 6-9 month" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-04-01" />
          <period-end iso-date="2026-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 2142; Denominator: 2407; Percentage: 88.99%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 2415; Denominator: 2714; Percentage: 88.98%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-04-01" />
          <period-end iso-date="2027-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 2072; Denominator: 2276; Percentage: 91.04%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-10-01" />
          <period-end iso-date="2028-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 2335; Denominator: 2566; Percentage: 91%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 2473; Denominator: 4110; Percentage: 60.17%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1609; Denominator: 1722; Percentage: 93.44%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 113; Denominator: 1722; Percentage: 6.56%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 702; Denominator: 1722; Percentage: 40.77%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1020; Denominator: 1722; Percentage: 59.23%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 704; Denominator: 1722; Percentage: 40.88%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 1014; Denominator: 1722; Percentage: 58.89%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Provider type" value="Public" />
          <comment>
            <narrative>Numerator: 1722; Denominator: 1722; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Treatment regimen" value="Shorter 6-9 month" />
          <comment>
            <narrative>Numerator: 506; Denominator: 1722; Percentage: 29.38%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 4; Denominator: 1722; Percentage: 0.23%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 1515; Denominator: 2104; Percentage: 72.01%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 0; Denominator: 1568; Percentage: 0%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1174; Denominator: 1568; Percentage: 74.87%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 61; Denominator: 1568; Percentage: 3.89%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 492; Denominator: 1568; Percentage: 31.38%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 743; Denominator: 1568; Percentage: 47.39%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 514; Denominator: 1568; Percentage: 32.78%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 720; Denominator: 1568; Percentage: 45.92%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Public" />
            <comment>
              <narrative>Numerator: 1235; Denominator: 1235; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Shorter 6-9 month" />
            <comment>
              <narrative>Numerator: 1235.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 1; Denominator: 1568; Percentage: 0.06%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-04-01" />
          <period-end iso-date="2026-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 1291; Denominator: 1745; Percentage: 73.98%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 1450; Denominator: 1959; Percentage: 74.02%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-04-01" />
          <period-end iso-date="2027-09-30" />
          <target>
            <comment>
              <narrative>Percentage: 75%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-10-01" />
          <period-end iso-date="2028-03-31" />
          <target>
            <comment>
              <narrative>Percentage: 75%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of laboratories successfully participating in external quality assurance (EQA) or proficiency testing (PT) schemes</narrative>
      </title>
      <description>
        <narrative>Module: RSSH/PP: Laboratory systems (including national and peripheral).</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of laboratories successfully participating in external quality assurance (EQA) or proficiency testing (PT) schemes</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2024" iso-date="2024-12-31" value="91.43">
          <comment>
            <narrative>Numerator: 32; Denominator: 35.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target value="97.14">
            <comment>
              <narrative>Numerator: 34; Denominator: 35.</narrative>
            </comment>
          </target>
          <actual value="0">
            <comment>
              <narrative>Numerator: 0; Denominator: 35.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-04-01" />
          <period-end iso-date="2026-09-30" />
          <target value="97.14">
            <comment>
              <narrative>Numerator: 34; Denominator: 35.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target value="97.14">
            <comment>
              <narrative>Numerator: 34; Denominator: 35.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-04-01" />
          <period-end iso-date="2027-09-30" />
          <target value="97.14">
            <comment>
              <narrative>Numerator: 34; Denominator: 35.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-10-01" />
          <period-end iso-date="2028-03-31" />
          <target value="97.14">
            <comment>
              <narrative>Numerator: 34; Denominator: 35.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of reporting units which digitally enter and submit data at the reporting unit level using the electronic information system</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Monitoring and evaluation systems.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of reporting units which digitally enter and submit data at the reporting unit level using the electronic information system</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2025" iso-date="2025-12-31" value="1.18">
          <comment>
            <narrative>Numerator: 39; Denominator: 3300.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target value="10.61">
            <comment>
              <narrative>Numerator: 350; Denominator: 3300.</narrative>
            </comment>
          </target>
          <actual value="2.18">
            <comment>
              <narrative>Numerator: 72; Denominator: 3300.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-04-01" />
          <period-end iso-date="2026-09-30" />
          <target value="56.06">
            <comment>
              <narrative>Numerator: 1850; Denominator: 3300.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target value="92.42">
            <comment>
              <narrative>Numerator: 3050; Denominator: 3300.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-04-01" />
          <period-end iso-date="2027-09-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 3300; Denominator: 3300.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-10-01" />
          <period-end iso-date="2028-03-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 3300; Denominator: 3300.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>HR-Other 1 Number of healthcare workers trained on Human Rights and Medical Ethics</narrative>
      </title>
      <description>
        <narrative>Module: Reducing human rights-related barriers to HIV/TB services.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>HR-Other 1 Number of healthcare workers trained on Human Rights and Medical Ethics</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2025" iso-date="2025-12-31" value="10067" />
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target value="1668" />
          <actual value="0">
            <comment>
              <narrative>Denominator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-04-01" />
          <period-end iso-date="2026-09-30" />
          <target value="2083" />
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target value="2083" />
        </period>
        <period>
          <period-start iso-date="2027-04-01" />
          <period-end iso-date="2027-09-30" />
          <target value="2083" />
        </period>
        <period>
          <period-start iso-date="2027-10-01" />
          <period-end iso-date="2028-03-31" />
          <target value="2083" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2024" iso-date="2024-12-31">
          <comment>
            <narrative>Numerator: 100761.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 64332; Denominator: 100761; Percentage: 63.85%.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 48362; Denominator: 100761; Percentage: 48%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 56842.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-04-01" />
          <period-end iso-date="2026-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 48065.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 54201.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-04-01" />
          <period-end iso-date="2027-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 45448.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-10-01" />
          <period-end iso-date="2028-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 51250.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2024" iso-date="2024-12-31">
          <comment>
            <narrative>Numerator: 88056; Denominator: 100761; Percentage: 87.39%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 50589; Denominator: 56842; Percentage: 89%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-04-01" />
          <period-end iso-date="2026-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 43259; Denominator: 48065; Percentage: 90%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 48781; Denominator: 54201; Percentage: 90%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-04-01" />
          <period-end iso-date="2027-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 41358; Denominator: 45448; Percentage: 91%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-10-01" />
          <period-end iso-date="2028-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 46638; Denominator: 51250; Percentage: 91%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="76.55">
          <comment>
            <narrative>Numerator: 76780; Denominator: 100299.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target value="86">
            <comment>
              <narrative>Numerator: 45927; Denominator: 53403.</narrative>
            </comment>
          </target>
          <actual value="0">
            <comment>
              <narrative>Numerator: 0; Denominator: 49817.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-04-01" />
          <period-end iso-date="2026-09-30" />
          <target value="88">
            <comment>
              <narrative>Numerator: 44358; Denominator: 50407.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target value="88.01">
            <comment>
              <narrative>Numerator: 50024; Denominator: 56842.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-04-01" />
          <period-end iso-date="2027-09-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 43258; Denominator: 48065.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-10-01" />
          <period-end iso-date="2028-03-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 48780; Denominator: 54201.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB/DR-TB Prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2024" iso-date="2024-12-31">
          <comment>
            <narrative>Numerator: 34974.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 9883; Denominator: 34974; Percentage: 28.26%.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31">
          <dimension name="Provider type" value="Public" />
          <comment>
            <narrative>Numerator: 34974; Denominator: 34974; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 28713.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Public" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-04-01" />
          <period-end iso-date="2026-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 37433.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 40552.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-04-01" />
          <period-end iso-date="2027-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 46819.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-10-01" />
          <period-end iso-date="2028-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 50721.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2024" iso-date="2024-12-31">
          <comment>
            <narrative>Numerator: 45615; Denominator: 48362; Percentage: 94.32%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 25908; Denominator: 27271; Percentage: 95%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-04-01" />
          <period-end iso-date="2026-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 19738; Denominator: 20776; Percentage: 95%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 22257; Denominator: 23429; Percentage: 95%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-04-01" />
          <period-end iso-date="2027-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 18861; Denominator: 19854; Percentage: 95%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-10-01" />
          <period-end iso-date="2028-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 21269; Denominator: 22389; Percentage: 95%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV currently enrolled on antiretroviral therapy who started TB preventive treatment (TPT) during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV currently enrolled on antiretroviral therapy who started TB preventive treatment (TPT) during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2024" iso-date="2024-12-31">
          <comment>
            <narrative>Numerator: 130888; Denominator: 6230200; Percentage: 2.1%.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 9883.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 196332; Denominator: 7068106; Percentage: 2.78%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 0; Denominator: 6268541; Percentage: 0%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 294498; Denominator: 7473675; Percentage: 3.94%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-10-01" />
          <period-end iso-date="2028-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 441747; Denominator: 7880155; Percentage: 5.61%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV and currently on antiretroviral therapy who are receiving multi month dispensing of antiretroviral medicine</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV and currently on antiretroviral therapy who are receiving multi month dispensing of antiretroviral medicine</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2024" iso-date="2024-12-31" value="41.11">
          <comment>
            <narrative>Numerator: 2405441; Denominator: 5851473.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target value="42.46">
            <comment>
              <narrative>Numerator: 2817360; Denominator: 6635142.</narrative>
            </comment>
          </target>
          <actual value="41.68">
            <comment>
              <narrative>Numerator: 2612489; Denominator: 6268541.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-04-01" />
          <period-end iso-date="2026-09-30" />
          <target value="42.19">
            <comment>
              <narrative>Numerator: 2958228; Denominator: 7011311.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target value="44.2">
            <comment>
              <narrative>Numerator: 3099096; Denominator: 7011311.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-04-01" />
          <period-end iso-date="2027-09-30" />
          <target value="44.05">
            <comment>
              <narrative>Numerator: 3254051; Denominator: 7387862.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-10-01" />
          <period-end iso-date="2028-03-31" />
          <target value="46.14">
            <comment>
              <narrative>Numerator: 3409006; Denominator: 7387862.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2024" iso-date="2024-12-31" value="77.59">
          <comment>
            <narrative>Numerator: 6230200; Denominator: 8029480.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31" value="65.11">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 5228360; Denominator: 8029480.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31" value="32.93">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 2643710; Denominator: 8029480.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target value="87">
            <comment>
              <narrative>Numerator: 7068106; Denominator: 8124260.</narrative>
            </comment>
          </target>
          <actual value="79.19">
            <comment>
              <narrative>Numerator: 6268541; Denominator: 7916310.</narrative>
            </comment>
          </actual>
          <actual value="82.81">
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 4221180; Denominator: 5097180.</narrative>
            </comment>
          </actual>
          <actual value="71.09">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1861320; Denominator: 2618400.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-04-01" />
          <period-end iso-date="2026-09-30" />
          <target value="88.53">
            <comment>
              <narrative>Numerator: 7270890; Denominator: 8212830.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target value="91">
            <comment>
              <narrative>Numerator: 7473675; Denominator: 8212830.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-04-01" />
          <period-end iso-date="2027-09-30" />
          <target value="92.55">
            <comment>
              <narrative>Numerator: 7676915; Denominator: 8294900.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-10-01" />
          <period-end iso-date="2028-03-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 7880155; Denominator: 8294900.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>